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ABSTRACT 
 
JUDY FOXWORTH:  Effects of Shock Absorbing Insoles on Knee Pain, Functional 
Mobility, and Lower Extremity Biomechanics in Persons with Symptomatic Knee 
Osteoarthritis 
 
(Under the direction of Darin Padua) 
 
Osteoarthritis (OA) is a progressive, chronic disease causing pain, limited function, and 
decreased quality of life.   
Purpose:  To investigate the effects of shock absorbing insoles (SAI) on knee pain, 
functional mobility and lower extremity biomechanics in persons with knee OA and to 
identify any modifiers of the effects of SAI on knee pain.  
Methods:  Sixty community-dwelling seniors (age 63.9 + 8.8 years) with knee OA and pain 
completed a demographic form, Western Ontario and McMaster University Osteoarthritis 
Index, Arthritis Self Efficacy Scale, and three walking tasks under two conditions:  1) with 
SAI placed inside the shoe and 2) shoes alone.  The walking tasks were: 1) usual pace; 2) fast 
pace; 3) six minute walk test (6MWT).  After each walking task, participants rated their knee 
pain.  Participants also completed a three dimensional (3-D) gait analysis.   
Data Analysis:  Separate one-way within subject repeated measures ANOVA’s were used to 
compare outcome variables.  An ANCOVA was used to determine if subject characteristics 
modified the effects of the SAI on knee pain during the 6MWT.   
Results:  Participants reported significantly less pain after walking six minutes while 
wearing the SAI (26 + 25.7 mm) as compared to shoes alone (31.4 + 28 mm, F1,59 = 5.067, p 
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= .028, ES = .079, 1-β=60).  No significant differences in knee pain (with or without SAI) 
were found during the other walking conditions.  From the 3-D gait analysis, there were no 
significant differences in the time to reach peak vertical ground reaction force (VGRF), peak 
VGRF, loading rate, peak knee flexor moment or average knee moment between the two 
conditions.  No significant interactions were found between select physical characteristics 
and changes in knee pain during the 6MWT while wearing the SAI.   
Conclusion:  The use of SAI appears to decrease knee pain in persons with knee OA when 
walking for sustained periods.  Weight, knee OA severity, WOMAC score, hip-knee-ankle 
angle or ASES pain subscore do not appear to modify the effects of the SAI on knee pain 
during the 6MWT.  Kinetic variables associated with an increase in shock absorption were 
not significantly different during the SAI condition.   
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CHAPTER 1 
INTRODUCTION 
 
 Osteoarthritis (OA) is the most prevalent, progressive form of arthritis affecting more 
than 20 million Americans 1-3 and causing a tremendous health care burden.4  Persons with 
OA seek medical care at about twice the rate of non-affected persons 1 with direct costs of 
nearly $60 billion dollars in the United States.1  When factoring in work–related losses, this 
burden increases to $155 billion dollars per year.2  
 The prevalence of OA has age and gender specific patterns.  In general, the prevalence of 
OA increases with age.1-3, 5, 6  Less than 5 percent of people between 15 and 44 years of age 
report symptoms of OA 1; however, the prevalence of OA drastically increases beyond this 
age range.  In the year 2000, 80% of persons 65 years and older in the United States were 
affected by OA.4  There is a higher prevalence of OA in men prior to age 50, while after age 
50, women are more likely to be affected.2   
 Because of the strong association with age, the prevalence of OA is anticipated to 
increase by epic proportions.   It is estimated that by the year 2012, OA will be the fourth 
largest health impact among women and eighth among men.5  According to the Center for 
Disease Control7, the population of 65 and older has been growing at a rate nearly twice as 
fast as their younger counter-parts.  It is expected over the next twenty years that persons 
over the age of 65 will dramatically increase as baby boomers age.  The population is also 
living longer.  The average life span for a person living in America is 77.9 years.7  The    
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combination of longer life span and the strong relationship between OA and age is certain to 
increase the impact of OA on society.  More people, living longer, will require more services 
for the management of chronic diseases including OA.    
Osteoarthritis may affect one or more joints and is classified as either primary or 
secondary OA.  Primary OA is often referred to as idiopathic OA because the etiology of the 
disease is unknown.8  Non-modifiable risk factors for primary OA include age, gender and 
genetics.9  Persons are classified with secondary OA when the etiology of the disease can be 
attributed to one or more modifiable risk factors.8  Modifiable risk factors for the 
development and/or progression of knee OA include joint laxity5, joint malalignment10, 
muscle weakness11, obesity12, and repetitive high rates of impact loading13 of the lower 
extremities.  Social factors such as low education level and low socioeconomic status may 
also influence the progression of OA.14  While the diagnosis of OA includes primary and 
secondary classifications, this classification has not been widely used in research focusing on 
OA.   
   Osteoarthritis is characterized by a break-down of articular cartilage leading to 
radiographic changes, and symptoms including pain, stiffness, joint inflammation and 
crepitis.8  The natural history of OA results in irreversible damage to joint structures, 
including cartilage, bone and joint capsule.15  The impact of OA on disability is significant.  
Disability is usually defined as needing some assistance with walking and difficulty climbing 
stairs.3  For persons with knee OA the risk of disability is greater than any other medical 
condition with the exception of cardiovascular disease.16  Factors linked to disability in 
patients with OA include pain 3,1, 6, muscle weakness 1, 3, 4, joint stiffness 6 and changes in 
balance.3, 17, 18                      
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The knee joint is the most common weight bearing joint involved in OA.3, 4, 18  Evidence 
indicates 11% of women and 7% of men aged 63 to 75 years reported symptomatic knee 
OA.4  In that same cohort, 31% of males and 34% females had radiological signs of knee 
OA.  The knee’s vulnerability to osteoarthritis is in part due to poor joint design and lack of 
lateral stability.11  The knee joint is particularly vulnerable because of the tremendous 
repetitive impact loading which occurs during functional activities such as walking and stair 
climbing.15   
At this time there is no known cure for OA.  The focus of current treatments for knee OA 
is either palliative or surgical.  The goal of both approaches is to decrease joint pain to 
decrease functional limitations.19-21  Palliative treatments may include either pharmacological 
or nonpharmocological modalities.20, 22  The American College of Rheumatology 
recommends a combination of both pharmacological and non-pharmocological treatments for 
the medical management of knee OA.20  Surgical interventions such as a total joint 
replacement are only recommended for those with severe pain who have not responded to 
previous medical management.20, 21  Nonpharmocological interventions include patient 
education, weight loss (if overweight), exercise programs, shock-absorbing footwear, heel 
wedged orthotics and bracing. 20, 21   
In order for nonpharmocological interventions to be effective in the treatment of knee 
OA, they must be accessible and cost effective.  As discussed previously, repetitive impact 
loading, which occurs in functional activities such as walking has been associated with the 
progression of knee OA.15  A shock absorbing insole placed in the shoe should decrease the 
compressive joint loading up the kinetic chain to the knee.  Shock absorbing insoles range in 
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price from $10 to $50 depending on the brand and can be purchased without a doctor’s 
prescription at most general stores.   
There is research supporting the use of SAI in other young active populations to reduce 
overuse injuries and increase comfort.23-26  However, there is very little empirical evidence to 
support the use of SAI in seniors.  If proven effective in reducing pain in persons with knee 
OA, shock absorbing insoles would be a simple and easily implemented intervention to allow 
persons with knee OA to perform functional activities such as walking with less pain.   
Purpose: 
The purpose of this study is to examine the immediate effects of shock absorbing insoles 
on knee pain, functional mobility, and lower extremity biomechanical characteristics in 
persons with knee osteoarthritis (OA).  A second purpose is to determine whether certain 
demographic, lower extremity alignment, or health-related characteristics modify the effects 
of the shock absorbing insoles.  
Specific Aim 1:  To determine the immediate effects of shock absorbing insoles (SAI) on 
knee pain during walking, walk distance, and gait speed in persons with symptomatic 
knee OA. 
Research Question 1:  What is the effect of SAI on knee pain measured using a visual analog 
scale (VAS) during walking in persons with symptomatic knee OA?  
Hypothesis:  Persons with symptomatic knee OA will report less pain on the VAS during 
walking tasks while wearing SAI. 
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Table 1.1  Outcome measures for Aim 1 - Research Question 1. 
 
 
 
 
 
 
 
 
Research Question 2:  What is the effect of SAI on distance walked in persons with 
symptomatic knee OA? 
Hypothesis:  Persons with symptomatic knee OA will walk farther during the 6 minute walk 
while wearing SAI.  
Table 1.2.  Outcome measures for Aim 1 - Research Question 2. 
Task SAI 
 Without With 
 
6 min walk 
 
Distance 
 
Distance 
Research Question 3:  What is the effect of SAI on gait speed in persons with symptomatic 
knee OA? 
Hypothesis:  Persons with symptomatic knee OA will walk faster while wearing SAI. 
 
Table1.3.  Outcome measures for Aim 1 - Research Question 3. 
 
 
  
 
 
Specific Aim 2:  To determine the immediate effects of shock absorbing insoles on lower 
extremity biomechanical characteristics in persons with symptomatic knee OA. 
Task SAI 
  Without With 
 
6 min. walk 
 
VAS VAS 
Fast Gait Speed 
 
VAS VAS 
Self-Selected Speed VAS VAS 
Task SAI 
 Without With 
 
Fast Gait Speed 
 
 
Time 
 
 
Time 
Self-Selected Gait Speed Time Time 
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Research Question 1:   What is the effect of SAI on lower limb kinetics during the loading 
response of the stance phase of walking in persons with symptomatic knee OA? 
Hypothesis 1:   Persons with symptomatic knee OA will have a decrease in the rate of 
loading during the loading response of stance while wearing a SAI. 
Hypothesis 2:  Persons with symptomatic knee OA will have an increase in the time to peak 
vertical ground reaction force (VGRF) during the loading response of stance while 
wearing a SAI. 
Hypothesis 3:  Persons with symptomatic knee OA will have a decrease in the peak vertical 
ground reaction force (VGRF) during the loading response of stance while wearing a  
SAI. 
Hypothesis 4:  Persons with symptomatic knee OA will have a decrease in the external knee 
extensor moment during the loading response of stance while wearing a SAI. 
Hypothesis 5.  Persons with knee OA will have a decrease in the sagittal plane external 
average knee moment during loading response of stance while wearing a SAI.  
Table 1.4.  Outcome measures for Aim 2 - Research Question 1. 
Task SAI 
 Without With 
 
Rate of Impact Loading   
 
Times BW/sec 
 
Times BW/sec 
 
Time to peak VGRF 
 
Sec 
 
Sec 
 
Peak VGRF 
 
N 
 
N 
 
Peak external knee flexion moment  
during loading response of stance 
 
N/ kg * HT 
 
N/kg * HT 
Average external knee moment 
during loading response of stance  
N/ kg*HT Nm/kg*HT 
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Weight 
Severity of knee OA 
Initial WOMAC Pain Subscore 
Hip-knee-ankle angle 
Arthritis Self-efficacy Pain Subscore  
Specific Aim 3:  To determine whether subject characteristics of body weight, severity of 
OA, initial pain level, hip-knee-ankle angle and Arthritis Self Efficacy score (ASES) 
modify the effects of the SAI on knee pain.  
Figure 1.1  Model depicting predicted modifiers of shock absorbing insoles.  
 
 
 
 
 
 
 
 
Research Question 1:  Does weight, severity of OA, initial pain level, hip-knee-ankle angle 
and Arthritis Self Efficacy pain score (ASES) modify the effects of SAIs on pain during 
the six-minute walk? 
Hypothesis 1:  Lighter weight people will report a greater decrease in pain, relative to heavier 
people, during the six minute walk while wearing SAIs. 
Hypothesis 2:  People with less severe knee OA as measured by the KL grading scale will 
report a greater decrease in pain during the six minute walk while wearing SAIs.  
Hypothesis 3:  People with less pain as measured by the WOMAC pain subscale will report a 
greater decrease in pain during the six minute walk while wearing SAIs. 
Hypothesis 4:  People with less hip-knee-ankle angle will report a greater decrease in pain 
during the six minute walk while wearing SAIs.  
Shock Absorbing 
Insoles 
Knee pain during 6MWT  
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Hypothesis 5:  People with a higher sense of self-efficacy regarding pain, as measured by the 
Arthritis Self-efficacy Pain Subscale, will report a greater decrease in pain during the six 
minute walk while wearing SAIs.  
 
 
CHAPTER 2 
LITERATURE REVIEW 
  This chapter is divided into 5 sections: 1) OA of the Knee: Pathophysiology, Pain, & 
Functional Limitations; 2) Measures of Pain & Functional Mobility; 3) Biomechanics of Gait 
in People with Knee OA; 4) Treatments for Knee OA;  and 5) Shock-Absorbing Insoles. 
Each section will describe the most current literature regarding the topic area. 
OSTEOARTHRITIS OF THE KNEE: PATHOPHYSIOLOGY, PAIN & PHYSICAL 
ACTIVITY  
 The pathophysiology of osteoarthritis is characterized by progressive cartilage damage 
and sclerosis of the underlying subchondral bone.  Osteoarthritis develops when the 
extracellular matrix in the articular cartilage fails secondary to proteoglycan depletion. 27  
The cartilage loses its normal stiffness and “bottoms out” more easily with repeated or 
prolonged loading.  Normal weight-bearing forces are delivered to a thinning articular 
cartilage causing more of the forces to be absorbed by the underlying bone.  Bone is formed 
in response to this additional mechanical loading causing an increase in the subchondral bone 
density.27  This feed-forward mechanism guarantees a progression of symptoms over time. 
Knee OA and Pain   
Knee pain is the primary symptom which urges persons with knee OA to visit the doctor.5   
Joint pain and stiffness are primary indicators of the presence of OA and are usually mild in 
the beginning and progresses with disease severity.5, 8   Pain intensity is variable and usually 
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worsens after activity or prolonged inactivity.5  Pain may occur at rest and at night with 
more advanced joint involvement.5  Pain control is the major goal of recommended OA 
treatment regimes for both nonsurgical and surgical interventions.20, 21  
 There is strong evidence that pain is poorly correlated with radiological disease in 
osteoarthritis.5, 28   Physicians routinely use the Kellgren-Lawrence scoring system 29 to 
diagnosis OA and determine the disease severity. This classification system depends on 
the presence of joint space narrowing and bony changes as viewed with radiographs.  The 
grading scale is from 0 – 4 with a grade of 0 given when there is no evidence of joint 
changes and a grade of  4 given when the most severe bony changes are noted.29  
Clinically, it is common for a person with severe knee pain to have only mild 
radiographic changes.  It is also equally common for a person to have mild symptoms in 
the presence of severe joint radiographic evidence of disease.  The literature supports this 
clinical finding.  In a group of elders with knee OA (n = 50), there was not a significant 
correlation between pathology (Kellgren-Lawrence grading scale) and pain (r=.06).28  
Radiographs are the gold standard to diagnose knee OA.29  However, after initial 
diagnosis, radiographs are not helpful to determine disease progression.5    
 Longitudinal studies of persons with knee OA indicate that pain is one of the primary 
factors which impacts function.28, 30-31 Persons with greater knee OA pain intensity at 
baseline were more likely to report a decline in function over a three year period.30  In a 
group of fifty community dwelling elders with knee OA, pain was positively correlated (r 
= .80) with self reported function.28  Greater knee pain severity has also been shown to be 
associated with early functional limitations in women with knee OA.31  Knee OA pain 
increases the likelihood of having clinically relevant changes in function over a two year 
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period in people 46-56 years of age with knee OA, even after adjusting for age, gender 
and BMI.32  These studies support the idea that pain is a significant contributor to 
decreased function in those with knee OA.   
 Joint pain is a primary symptom of knee OA and impacts both self-reported and 
physical performance functional abilities in those with knee OA.  Research suggests that 
those with greater knee pain not only have more functional deficits but also have a 
greater decline in function with time.  Therefore, any proposed intervention for knee OA 
should have a primary objective of decreasing pain.   
Knee OA and Physical Activity 
 Physical activity is associated with a range of health benefits and its absence can have 
harmful effects on overall health and well being.  Inactivity can increase the risk of other 
systemic diseases such as cardiovascular disease, obesity, and diabetes.7  The CDC 
recommends that adults engage in at least 30 minutes of moderate-intensity physical 
activity 5 – 7 days per week.7  Seventy percent of the estimated 60 million Americans 
with arthritis currently do not meet the recommended guidelines for physical activity.3  
 People with knee OA who participate in physical activity programs can improve 
function without an increase in pain.33, 34  In fact, most studies report a decrease in pain 
after completing some sort of physical activity.33, 35  For example, participants with knee 
OA (n=90) randomly assigned to complete either a quadriceps exercise or  walking 
program  reported  significantly less pain (p<.001) after three months compared to those 
in the no exercise group.33  Researchers conducting a large  randomized clinical trial 
(N=600) investigating the effectiveness of a  home exercise program for individuals with 
knee pain secondary to OA, reported a significant reduction in pain for the exercise 
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groups compared to the non-exercise group at 6, 12, 18 and 24 month follow-up.35  
Results from another randomized trial (n=365) comparing aerobic exercise and resistance 
exercise to a health education program in older adults with knee osteoarthritis indicated a 
reduction in knee pain of 12% and 8% respectively for the exercise groups.34  Even 
though the evidence is overwhelmingly in favor of exercise to reduce knee pain in 
persons with osteoarthritis, physical inactivity is very common, especially among the 
elderly with OA.   
 Persons with knee OA may be more interested to begin and continue exercise 
programs if they feel they can control their symptoms.  Self-efficacy (SE) regarding 
symptom management has been determined as an important factor in exercise 
participation, adherence and effectiveness of nonpharmocological interventions.36  Self-
efficacy is defined as the belief in one’s capability to do a specific task or achieve a 
certain result.37  Research supports SE as an influential factor in determining physical 
function in persons with knee OA.28, 30, 38   Sharma and colleagues 30 reported SE scores 
predicted both self-report and physical performance measures over a 3-year period in 
persons with knee OA (n=257).  Participants (n=51) completing a community based 
exercise program, (PACE - people with arthritis can exercise) emphasized the important 
role of SE in maintaining physical activity.39 
Summary Of Activity Level In Persons With Symptomatic Knee OA  
 Moderate physical activity is recommended by the CDC to improve overall health 
and well being however, a very small percentage of people with knee OA participate in 
regular exercise.  People with symptomatic knee OA walk slower in an attempt to 
decrease knee pain.  This slower walking speed further reduces aerobic capacity and may 
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impact the capability of these individuals to develop and/or maintain a more active 
lifestyle.   
 The literature also supports the importance of self-efficacy in persons with knee OA.  
People with knee OA and high pain self-efficacy believe they can perform activities and 
have some influence over their pain.  It is reasonable to assume that a shock absorbing 
insole may assist in decreasing the overall forces experienced by the knee joint during 
walking.  A decrease in knee joint forces should decrease knee pain.  An intervention 
which aides in decreasing knee pain during functional mobility may encourage people to 
engage in more physical activity.  Positive benefits of continued physical activity include 
a reduction in knee pain and better weight management in those with knee OA. 40  
MEASURES OF PAIN, FUNCTIONAL MOBILITY, AND SELF-EFFICACY 
 This section presents a review of the psychometric properties of and rationale for the 
measures that will be used in this study to assess pain, functional mobility, and self-
efficacy. 
 Pain Visual Analog Scale:  A common way to assess pain is by the use of a pain 
Visual Analog Scale (VAS). The VAS is a self-report instrument consisting of a 100 mm 
horizontal or vertical line.41  The line is anchored with two extremes of pain on either 
end:  “no pain” and  “worst imaginable pain”.  Participants are asked to rate their pain 
intensity by placing a single mark across the line.  The clinician then measures the 
distance from the “no pain” anchor to the mark placed on the line.  This distance is the 
score and can range from 0 to 100 with a higher score indicating more severe pain.  This 
measure has been tested with patients suffering from both acute and chronic pain.  
Convergent construct validity has been reported as high as .95 when the VAS was 
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compared to a numeric pain scale.42  The VAS has excellent test-retest reliability (.71 - 
.99).43  The minimum clinically significant difference on the VAS is 28 mm.43  The VAS 
is a valid and reliable measure of pain which can be used to quantify pain in those with 
knee OA. 
 Gait Speed:   Gait speed (GS) is considered by some to be the best measure of 
functional mobility.43  It combines both spatial and temporal measurements of gait by 
providing information on the distance walked in a given amount of time.  Gait speed is 
generally reported in meters per second (m/s).  Testing takes less than 1 minute and is 
easily administered in a clinical or lab setting.  Both intrasession (15 minute interval, 
r=0.97)) and intersession reliability (from 1 day, r=0.93 to 3 week interval, r=0.95) has 
been reported to be very good.43 
 Individuals with symptomatic knee OA are limited in simple mobility tasks such as 
walking community distances.  Walking is a common functional activity required for 
activities of daily living and is a component of functional mobility.43  In a group of elders 
with knee OA, there was a significant correlation between pain and self-reported function 
(r=.80, p<.001) as measured by the WOMAC physical function subscale.28  Even patients 
with unilateral painful knee OA have been found to walk more slowly than healthy 
controls.44  A large cross-sectional study (n = 139) found that persons with symptomatic 
knee OA walked slower (1.09 m/s) than those without knee OA (1.17 m/s).45  Messier et 
al18 recently reported subjects with knee OA demonstrated not only slower walking 
speeds, but also shorter stride lengths and a greater step width than age-matched controls.  
The same gait strategies were observed in middle aged females with early (stage 1) 
medial knee OA compared to healthy females.46  
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 The altered gait strategies, especially slower walking speed, in persons with knee OA 
may be a compensatory strategy to decrease forces across the knee joint thereby 
decreasing pain.18, 47, 48  Soft tissue forces such as muscle contractions are the major 
source of forces across any joint in the body.  Slower walking speeds require less muscle 
contractile force to be developed by the quadriceps.47  Messier et al49reported that slower 
walking speed resulted in lower joint forces and moments in persons with knee OA 
compared to healthy controls.  These data support the hypothesis that slower walking 
speeds is a learned compensation to decrease pain.      
 Current research supports that mobility impairments precede impairments in activities 
of daily living (ADL) in a well functioning population.50  In a healthy population of 
elderly persons age 75 and older, gait speed (GS) alone was able to predict 
hospitalization, new falls and the requirement of a caregiver in a two year follow-up.50 
These data indicates that slow GS in a healthy population may be the first indication that 
more compromising functional difficulties are imminent. Previous studies have 
determined that GS greater than 1 meter per second (m/s) is normal for healthy older 
adults.17, 40, 51. Gait speed of 1.3 m/s is needed to be able to cross an intersection safely.40   
 Six-Minute Walk Test:  Another performance based mobility task is the six-minute 
walk test (6MWT).  This test was originally developed to assess exercise tolerance 
among individuals with respiratory diseases 52 and is often used to assess mobility 
performance in older adults. 52  The 6MWT is a global assessment of functional mobility 
which summarizes both strength and endurance deficits due to cardiovascular and 
musculoskeletal systems .53  Participants are asked to cover as much ground as possible 
in 6 minutes.  The test should ideally be conducted in a long corridor which minimizes 
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turns.43  Reliability of the 6MTW has been reported to be very good (ICC = .98) in 
persons with arthritis.53 
 There are also standardized two and four minute walk tests which have been used to 
assess functional mobility in elderly populations.  The 6MWT, however, is the most 
commonly used test to assess functional mobility with older adults with symptomatic 
knee OA.53  In a large randomized controlled trial (N=252) evaluating the effects of diet 
and exercise in people with symptomatic knee OA 53 those who completed an exercise 
program alone or diet and exercise program showed significant improvement in distance 
walked during the 6MWT.  There were no reports of participants not being able to 
complete this test secondary to pain. 
 The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): 
The WOMAC is a widely used multidimensional, disease specific, self-report survey 
originally developed for people with hip and/or knee OA.53  It consists of 24 questions 
concerning joint pain, stiffness and physical function.30  Three subscores can be 
calculated with the maximum score of twenty for joint pain; eight for joint stiffness and 
sixty-eight for physical function.  The subscores can be reported individually or summed 
and reported as the WOMAC index or global score.  For both the global and subscores, 
lower scores indicate lower level of symptoms and/or disability.30, 33, 35, 40  This survey 
can be completed in five to ten minutes keeping the participant burden low.33, 35, 40     
 The WOMAC is available in a VAS version and a Likert scale version.  The VAS 
version uses the previously described 100 mm line for participants to rate the degree of 
pain, stiffness and level of physical disability.  The anchors on the VAS version are “no 
difficulty, pain or stiffness” and “extreme difficulty, pain or stiffness”.  The VAS version 
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is easy to administer, but labor intensive to score.  For that reason, the Likert version of 
the WOMAC is used more often.37  The five-point Likert version uses an ordinal scale of 
0 to 4 corresponding with the adjectives none, mild, moderate, severe and extreme.   
 The psychometric properties of the WOMAC have been well studied.37  Test-retest 
reliability for the pain subscales (.64 to .74) and the physical function subscales (.68 - 
.92) are good.37  However, the test-retest reliability of the stiffness subscale (.48 - .58) 
was not as reliable.54 Convergent construct validity of the physical function subscale with 
the SF-36 show good agreement (Spearman’s rank correlation coefficient = .75).   
 The WOMAC in its entirety and subscales have been used extensively in the 
literature to address self report outcomes in person with knee OA.  The WOMAC global 
score have been used to classify people with knee OA into poor and good outcomes in 
longitudinal studies.47 The WOMAC physical function subscore is often used in research 
studies as a primary measure of self-reported physical function. 47  The WOMAC pain 
subscore has also been used to assess knee pain.47  The WOMAC pain subscore is made 
up of questions regarding pain when performing certain activities over the last forty-eight 
hours, therefore it is not appropriate to use as a measure of pain while completing a 
specific task. 
 Arthritis Self-Efficacy Scale:  Self-efficacy can be evaluated by the Arthritis Self-
Efficacy Scale (ASES).  This tool is a self-administered disease-specific questionnaire 
consisting of 20 questions.  Three subscales scores can be compiled:  physical function 
self-efficacy (FSE); pain management self-efficacy (PSE); and other symptoms self-
efficacy (OSE).47  Participants are asked to choose a number on a scale from 10 (very 
uncertain) to 100 (very certain) to indicate their certainty they can perform a task.  A 
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higher score indicates higher SE.  This questionnaire takes approximately 10 minutes to 
complete. Test-retest reliability of the ASES was investigated in 91 people completing 
the survey twice within an average of 9 days.  Pearson correlation coefficients were 
reported to be .87 for PSE, .85 for FSE and .90 for OSE.55  There is no gold standard for 
comparison with the ASES to determine validity.  However, physical self-efficacy as 
measured with the ASES significantly correlated with task performance assessed in the 
client’s home (r=.61).48  Pain SE and levels of clinical pain reported on the Arthritis 
Impact Scale are moderately correlated (rho = .62).56 
 Summary of Measures  
 Functional mobility is affected by knee pain and can be measured by both physical 
performance and self-report measures.  The pain VAS is a valid and reliable tool used to 
measure a person’s perception of pain.  It is used extensively in both research and clinical 
settings.  The WOMAC is a self-report instrument designed specifically to assess joint 
pain, stiffness and physical function.  It can be used to classify persons with knee OA into 
different functional categories, different levels of physical function and pain. The ASES 
is a self-administered tool designed to assess a person’s self-efficacy in regards to pain 
control, physical self efficacy and symptoms related to OA.  Gait speed is a valid and 
reliable measure of both temporal and spatial attributes of ambulation.  The 6MWT  
assesses endurance deficits secondary to multiple systems and is a good indicator of 
overall physical function.  All of these measures are readily used to assess people with 
knee OA.   
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THE BIOMECHANICS OF GAIT IN PEOPLE WITH KNEE OA 
 This section discusses the kinetic and kinematic changes that take place in individuals 
with knee OA. Prior to a discussion of abnormal biomechanics, a review of the 
biomechanics of normal gait is presented. 
 Normal Gait 
 The phases of normal walking have been well described.47  A typical gait cycle 
consists of a stance and swing phase of one lower extremity.  The stance phase is further 
subdivided into weight acceptance, single limb support, and limb advancement. 47  The 
weight acceptance phase is the most demanding.  It involves the abrupt transfer of the 
body weight onto a limb which has an unstable alignment.   Weight acceptance comprises 
the first 10% of the gait cycle and is subdivided into two stages:  initial contact and 
loading response.  Initial contact is described as the instant the foot touches the floor.  
Loading response begins just after initial contact and continues until the opposite foot 
leaves the floor.47  The primary objective of the loading response is shock absorption 
which requires substantial muscle contractions of the lower extremity.47   
 At the end of swing phase, the foot is falling toward the ground.   When the foot hits 
the ground (initial contact) the momentum of the foot (and superincumbent body) is 
stopped by the ground.   Using Newton’s Third Law, the forces exerted by the ground 
(ground reaction forces, GRF) on the foot are equal to, but opposite in direction, of the 
forces exerted by the foot (foot forces) on to the ground.   The amount of force exerted 
onto the foot (GRF) is directly related to the rate of change in momentum of the foot and 
superincumbent body as it comes to a stop. The rate of change in momentum is 
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determined by the speed of the foot and the overall mass which must be decelerated 
during heel strike.55  
 The GRF generated during the stance phase of walking can be measured using a force 
plate.  During normal walking the vertical GRF demonstrates a very distinct curve with 
two peaks.  The first peak is referred to as the “weight acceptance” or “loading” peak and 
is usually slightly greater than the body weight.  A larger than body weight vertical GRF 
is needed to decelerate the downward movement of the body.  The second peak is 
referred to as the “propulsion peak” and represents the force needed to propel the body 
forward.48    
 The impact of the heel striking the ground during normal gait sends a stress wave up 
the lower limb.56  Knee flexion at heel strike, the heel pad and articular cartilage in joints 
are the body’s natural defenses against the detrimental effects of these stresses.55  Ankle 
plantarflexion and knee flexion occurring after initial contact are important shock 
absorbing mechanisms of the lower extremity.47  The heel pad absorbs up to 80% of the 
tibia acceleration in human cadaver specimens.24  There is also support that confinement 
of the heel pad within the heel counter of a shoe augments the heel pad’s ability to absorb 
shock by limiting the amount of heel pad compression at  heel strike.57    
 Sagittal plane knee motion during the stance phase of normal walking is well 
described.48  At heel strike the knee is flexed approximately 5 degrees and it continues to 
flex to 15 to 20 degrees during the loading response.  This additional knee flexion serves 
as a shock absorption mechanism as the body weight is transferred from the opposite 
limb.  Shock absorption is a functional obligation of the knee.47  Knee flexion during this 
period is controlled by an eccentric action of the quadriceps.  Following this initial 
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flexion, the knee extends to nearly full extension until heel off (when the heel lifts off the 
ground).  Knee extension during the stance phase is a result of a concentric quadriceps 
contraction.  
 A moment is the tendency of a force to cause a rotational movement about an axis.  It 
is defined by the product of the force times the perpendicular distance of that force from 
the axis of movement.58  Joint moments can be described in all three planes or as a 
resultant.  A resultant moment is the sum of all the moments acting on a joint secondary 
to bony and soft tissue forces.  In gait, both forces and moments are measured on the 
distal segment (foot) by the force plate.  By using the inverse dynamic procedure, joint 
moments and forces can be calculated for more proximal segments.58  Moments can 
either be described as external (secondary to forces on the extremity) or internal 
(secondary to the muscles to counteract the external moments).  According to Newton’s 
third law, internal moments are equal in magnitude, but opposite in direction, to the 
external moments.   
 The sagittal plane moments of the knee during the stance phase of normal gait have 
been well described.47  At heel strike there is a brief external extension moment (first 4% 
of the gait cycle).  This quickly changes to an external flexion moment during the loading 
response.47  The quadriceps acts eccentrically to control the amount of knee flexion 
during this period of gait.47    
 Biomechanical Changes in Walking Associated with Knee OA 
 Abnormal biomechanical stresses occurring during the loading response that lead to 
changes in the articular cartilage and the underlying subchondral bone are thought to play 
a significant role in the development of OA in the lower extremities.20  Repetitive loading 
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of the lower extremities that occurs during normal walking has been identified as a risk 
factor for the progression of knee OA.13   There is a greater potential for damage to both 
articular cartilage and the subchondral bone when the loading is more rapid.13   
 Animal studies suggest that repetitive impulsive loading in joints is a likely source of 
harmful stress leading to joint degeneration.59-61  Excised bovine joints were exposed to 
oscillating impulsive peak loading equal to the maximal load experienced by the tissue in 
vivo.  In all of these joints, articular cartilage wear developed and progressed rapidly.60  
Simon et al 59 subjected the knee joints of live guinea pigs to repetitive high rate (25 Hz) 
longitudinal impact loading over a 3 week period.  Degenerative changes of the knee 
such as tibia stiffness and cartilage fibrillation were apparent in these animals.59  Knee 
joints of live rabbits were subjected to a much briefer period of repetitive loading which 
more closely resembled the loading rate of normal walking.61  Impulsive loads equivalent 
to 1.5 times the animal’s body weight was delivered 40 times a minute for 20 -40 minutes 
per day.   All the joints developed stiffness of the underlying subchondral bone and 
multiple trabecular microfractures which is consistent with  damages found in joints with 
degenerative joint disease.61 
 Changes in Knee Flexion  
 Several studies indicate that people with knee OA have less peak knee flexion during 
the stance phase of walking.44-46, 51  Messier and colleagues 51 performed gait analysis on 
adults with knee OA (n=15) and age, mass and gender matched control subjects (n=15).  
They reported those with knee OA demonstrated decreased knee extension (mean = 5.5 
degrees) during gait.  Kaufman et al45 performed 3D gait analysis on persons diagnosed 
with grade 2 knee OA (n=139) and healthy participants (n=20) while walking.  Results 
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from these analyses indicated persons with knee OA had a mean of 6 degrees less peak 
knee motion than normal subjects (p<.001).  Al-Zahrani & Bakheit 44 performed gait 
analysis on participants with severe knee OA (n=58) and healthy age and sex matched 
controls (n=25).  The healthy subjects exhibited a mean of 14.3 degrees of knee flexion 
during loading response while the OA subjects only exhibited 4.4 degrees of knee flexion 
during this same time period.  In a study conducted by Gok et al46 females (n=13) with 
medial knee joint OA demonstrated significant decrease in knee flexion during stance 
compared to healthy females.  One study was found which reported no significant 
differences in midstance knee flexion during stance between participants with knee OA 
(n=31) and a comparison group of asymptomatic controls (n=31).  However, the knee OA 
participants in this study ranged from mild to severe knee OA and results were not 
reported according to severity.12   
 Walking with a “stiff” knee or a decrease in knee flexion during the loading response 
of gait causes a decrease in the shock absorbing ability of the lower extremity.  A 
possible mechanical pathogenesis of osteoarthritis is presented by Radin et al62 (Figure 
2.1.).  A loss of shock absorption leads to higher loads distributed across the knee joint 
which results in a breakdown of articular cartilage.  Even slightly higher loads delivered 
repetitively to the weight-bearing surfaces of the knee joint may cause articular cartilage 
to breakdown.59  
 Changes in Impact Loading Rates 
 It has been suggested that repetitive high impact loading rates could be a causal factor 
in the development of knee pain.13  Gait analyses were performed on subjects who had a 
history of activity-related tibiofemoral pain (n=18) and a control group (n=14).  The knee 
 24 
pain group demonstrated a significantly higher loading rate (67.6 + 22 BW/s) than the 
control group (47.9 + 14.4 BW/s). The knee pain group demonstrated altered eccentric 
muscle control of the quadriceps and less knee flexion during stance.  The authors 
concluded that the knee pain group demonstrated ineffective energy-absorbing 
mechanisms which resulted in hitting the ground harder and faster.  They termed this as 
“microklutziness” and suggested it plays a role in the development of  OA.62   
 Loading rate is a measure of shock absorption during the weight acceptance phase.  
One way of computing the loading rate is by dividing the vertical ground reaction force at 
the weight acceptance peak by the time it took to reach that peak.51, 63  The lower this 
number, the more shock absorption is taking place.  This method of computing loading 
rate does not factor in the presence of a heel transient.  A heel transient is a distinctive 
part of the vertical GRF.55  It is a sharp spike in the vertical GRF which occurs at the 
moment of initial contact or heel strike.55  It represents the termination of movement of 
the foot.  It is very short (10 – 20 ms) and is superimposed on the upslope of the ground 
reaction force.  This heel transient is very difficult to obtain when wearing shoes, in fact, 
less than 20% of the population demonstrate a heel transient while walking with shoes.55    
 An important distinction in the way impact loading rates are discussed can be 
demonstrated in the Radin et al62 study.  All the subjects in this study walked barefoot 
which allowed the measurement of the heel transient.  Impact loading rates calculated on 
the slope of the heel transient should not be compared with those calculated on the slope 
of the weight-acceptance peak.  Not enough information was given in this study to 
calculate the impact loading rate based on the peak vertical ground reaction force during 
the weight-acceptance curve.     
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 Messier and colleagues 51 compared impact loading rates while walking at a 
controlled speed (between 1.12 and 1.34 meters per second) among adults with 
symptomatic knee OA (n=15) and a group of age, mass, and gender-matched control 
subjects (n=15).  They found no difference in the impact loading rate of the affected 
knee, but did report an increased loading rate in the unaffected leg at heel strike. 51 Chen 
et al64, measured ground reaction force during walking with a group of healthy young 
adults (n=20), healthy elderly adults (n=15) and group of elderly with knee OA (n = 20).  
They reported an increase in the time to achieve peak vertical ground reaction force 
during the weight acceptance curve and a slight decrease in the weight acceptance peak in 
the elderly group with knee OA.  The researchers interpreted this to have an overall effect 
as to decrease the impact loading forces in persons with knee OA.  However, they did not 
actually compute or report impact loading rates.  They also did not adjust the kinetic data 
for walking speed even though they reported the elderly knee OA group walked at a 
significantly slower speed than the other groups. 
 Changes in Sagittal Plane Moments 
 There is conflicting evidence concerning sagittal plane moments of the knee during 
gait in individuals with knee OA.  Kaufman et al45, found OA subjects had lower internal 
knee extensor moments.  Baliunas et al12, reported no significant differences in knee 
moments between the group of OA subjects and the comparison group.  Al-Zahrani and 
Bakheit44 noted higher knee extensor moments during gait in the subjects with knee OA.  
Messier et al49, reported a 33.3% higher peak knee extension moment in an OA group.  
However, when the joint moments were adjusted for walking speed, there was not a 
significant difference.  Higher knee extension moments have the potential to increase 
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knee joint forces which, applied over a long period, may result in gradual degradation of 
the articular cartilage.49   
EFFECTIVE TREATMENTS FOR KNEE OA 
 The most common approach to the management of knee OA is a combination of drug 
therapy and non-pharmacologic strategies. These are discussed below. 
 Drug Therapies 
 The most common drug therapies include Acetaminophen, nonsteroidal anti-
inflammatory drugs (NSAIDS) and COX-2 specific inhibitors.  Acetaminophen has a 
lower risk of side effects and is often the first line of treatment to control pain in persons 
with knee OA.20  In clinical trials both NSAIDs and COX-2 inhibitors were more 
effective than acetaminophen in reducing pain.65   
 All of these drug therapies have known side-effects which may exclude an individual 
from participating in drug regimens.20  Acetaminophen is one of the safest analgesics, but 
can be associated with hepatic toxicity in patients with existing liver disease.20  For many 
patients, symptomatic relief is not attained with acetaminophen.  NSAIDs are often 
recommended as the next pharmacological intervention.  NSAIDs are effective in 
relieving symptoms, however, are strongly associated with adverse gastrointestinal events 
such as peptic ulcers and upper gastrointestinal bleeding.20  COX-2 inhibitors are drugs 
which can control the symptoms associated with OA and decrease the incidence of 
gastric complications.20, 66  However, high dosages of COX-2 inhibitors are associated 
with an increase risk of myocardial infarction, stroke and renal insufficiency.66   
 These pharmacological interventions are very costly.  A cohort in New Mexico living 
with OA incurred a mean cost of $4684.00 (U.S. dollars) per year for outpatient services 
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which included drug therapies.65  Prescription drug costs for those OA patients averaged 
$1184 per year which was spent on NSAIDs, gastric acid secretion reducers and 
antidepressants. 65   
 Custom-Fabricated Foot Orthotics  
 Custom fabricated, wedged foot orthotics is a non-pharmacological strategy with 
proven efficacy in persons with knee OA.67-70 Reports of clinical outcomes of lateral 
wedged insoles have been positive.  Wolfe and Brueckmann70 reported that lateral 
wedged insoles produced a decrease in resting and walking pain, and promoted an 
increase in activity level in persons with knee OA.  Sasaki and Yasuda67 reported lateral 
wedged insoles and medication (n= 67) reduced pain and improved walking tolerance in 
patients with medial knee OA compared to medication alone (n=40).  
 It is theorized that a rigid foot orthotic can better control foot motion and decrease 
frontal plane movements and forces at the knee.   For example, a person with medial knee 
OA who exhibits knee varus would be treated with a lateral wedged foot orthotic to 
decrease medial knee loading. Yasuda & Sasaki 71 suggested the lateral wedged insoles 
changed the spatial position of the femur and tibia to a more upright position, thereby 
decreasing the forces on the medial side of the knee.  Recent investigations have disputed 
this theory.  Static radiographical analysis of persons with medial knee OA (n=12) failed 
to identify differences in the hip-knee-ankle angle when standing with and without lateral 
wedged orthotics.69  Based on these studies it is unclear as to the mechanism by which 
custom fabricated orthotics improve symptoms associated with knee OA.        
 Ogata et al72 used an unidirectional accelerometer attached to the skin over the tibia to 
measure frontal plane movements of the lower leg in people without knee OA (n=40), 
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those with unicompartmental medial knee OA (n= 38) and unicompartmental lateral knee 
OA (n=10).  People with medial knee OA demonstrated a medial thrust of the tibia during 
the stance phase of walking while those with lateral knee OA demonstrated a lateral 
thrust of the tibia during this same period.  In persons with medial knee OA, the lateral 
thrust of the tibia was significantly reduced with the placement of a 5 degree lateral 
insole in the shoe.  In persons with lateral knee OA, the medial thrust of the tibia was 
significantly reduced by placement of a 5 degree medial insole in the shoe.72  They 
concluded that placement of a properly wedged insole in the shoe could alter the loading 
of the knee thereby decreasing the progression of knee OA.      
 Research involving three-dimensional motion analysis of walking with wedged 
insoles has produced mixed results regarding the biomechanical effects of wedged 
insoles.  Kerrigan et al68 compared lateral inclined wedged insoles of 5 degrees and 10 
degrees with a non-wedged even thickness insole placed in the shoe of participants with 
medial knee OA (n=15).  Peak knee varus torque was significantly reduced when wearing 
both the 5 and 10 degree wedged insoles, but not when wearing an insole.  The authors 
concluded that this reduction in knee varus torque in persons with medial knee OA could 
possibly slow the progression of the disease.68  Maly et al69 reported no differences in the 
knee adduction moment when walking with or without a 5 degree heel wedge.  They 
concluded that a lateral heel wedge did not reduce the loading on the medial knee joint.  
One possible explanation for this different finding is that they only placed the wedged 
orthotic under the heel, while Kerrigan et al used a lateral wedge under the entire foot.  
Neither of these studies evaluated the effectiveness of the wedged orthotics in decreasing 
knee pain.   
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 Although the literature generally suggests that custom fabricated foot orthotics are 
effective for pain relief of persons with medial knee OA, orthotics are expensive and  
often not covered by insurance plans.  A health practitioner must also gain advanced 
training to properly make and fit wedged orthotics to gain maximal benefit.  It is possible 
that some rural areas do not have appropriately trained personnel to offer this service.  
Custom foot orthotics range in price from $250 to $450 depending on the materials used 
and the health care professional who provides them.  For those with limited disposable 
income and/or who live in rural areas, this intervention may not be a viable option.      
 Knee Braces 
 A knee brace which is designed to unload one side of the knee joint during weight 
bearing activities is another external intervention which has been proven clinically 
effective.73, 74  These “unloader” knee braces utilize a 3-point bracing system to prevent 
varus or valgus thrust when walking.  A load-shifting brace significantly reduces the 
varus moment in persons with medial knee OA (n=5).73  Knee bracing has been reported 
to be more effective in relieving pain in those with moderate to severe (10 degrees) varus 
or valgus deformity.74  Generally, the cost of a custom knee brace ranges from $650 to 
$950.  Knee bracing is contraindicated in persons with OA of both compartments of the 
knee.74  Brace migration, skin breakdown, obesity, cost and patient comfort are 
significant barriers to patient compliance with knee bracing.73, 74 
 Sociobehavioral Interventions     
 Sociobehavioral interventions are less expensive non-pharmacological strategies with 
proven efficacy in pain reduction for persons with OA.3  Proven interventions include 
strength training and aerobic exercises33, 75, 76, diet and exercise40, walking programs33, 
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improving patient education regarding OA, and developing self-efficacy to manage the 
consequences of the disease.37  Participants who completed a three month home exercise 
program (n=30) or walking program (n=30) reported significant improvement in function 
and knee pain compared to those who did not exercise (n= 30).33  Data also indicate that  
participation in an exercise program reduced the incidence of an Activities of Daily 
Living (ADL) disability.   Penninx et al76, reported that persons with knee OA who did 
not complete an exercise program (n=80) were .57 times more likely to develop an ADL 
disability compared to those who completed either a resistance strengthening program 
(n=82) or an aerobic exercise program (n=88).   Even obese older adults have reported an 
increase in health related quality of life  after completing an eighteen month treatment 
program including a combination of diet and exercise.75  
 Although exercise improves pain and function in persons with knee OA, long-term 
adherence is essential to maintaining these gains.77  Because exercise programs are 
usually offered as an adjunct therapy and not as part of the medical management of OA, 
it is estimated that only 2% of the population with OA participates in these types of 
interventions.19  Some barriers to participation may include lack of availability, low self-
efficacy, cost, lack of trained personnel to lead groups, and adverse weather conditions.  
 Summary of Treatments for Knee Osteoarthritis 
 A combination of both pharmacological and nonpharmocological treatments have 
been proven effective in managing pain and functional decline in persons with knee 
OA.22  Custom wedged foot orthotics and knee bracing are expensive and not readily 
available to the general public.  Resistance and aerobic exercise programs are cost 
effective interventions for pain control and weight reduction, however, long term 
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compliance is low.  Walking programs are a low cost, easily accessible exercise 
intervention which have been proven effective in improving physical function without an 
increase in knee pain.  However, a person with knee pain may be resistant to begin a 
walking program for fear that knee pain will increase.  Shock absorbing insoles are a low 
cost, readily accessible adjunct to existing shoe wear which may decrease knee pain and 
improve mobility and encourage people with knee OA to move more.       
SHOCK ABSORBING INSOLES  
 The use of shock absorbing insoles (SAIs) has been suggested for people with knee 
OA to decrease pain and improve mobility during weight-bearing activities.22  Repetitive 
impact loading is a proven risk factor for the development of degenerative changes in 
both articular cartilage and subchondral bone.60-62  Augmentation of the body’s natural 
shock absorbing mechanisms would seem beneficial for individuals with musculoskeletal 
disease.24  Shock absorbing materials in shoes have been proven to attenuate forces 
experienced by weight-bearing joints.  Athletic shoes, which incorporate shock absorbing 
materials in their design, lower tibial “shock” (as measured with an accelerometer) 
compared to leather-soled shoes.57  
 Theoretical Framework for Testing Effectiveness of SAI     
 Basic biomechanical principles can be applied to normal walking to better understand 
the forces placed on the body.  Newton’s Laws describe how bodies react to forces placed 
upon them. The impulse-momentum relationship is based on Newton’s Law of 
Acceleration (F=ma) and describes how forces acting over a period of time can affect a 
body in motion.  Impulse is equal to the product of force (newtons) and the time 
(seconds) that force acted on the body; momentum is measured by the product of mass 
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and the change in velocity.  This relationship can be expressed in the following equation: 
F* t = mvfinal - mvinitial.  In order to change the momentum of an object, a greater force 
can be applied over a shorter period of time or a smaller force over a longer period of 
time.  
 One way to affect the forces needed to control the momentum of the body is to 
increase the time it takes for the body to come to a stop.  By manipulating the impulse-
momentum equation to isolate force, one can see the relationship “time” has in 
controlling momentum (F = mvfinal – mvinitial/ time).  Since time is in the denominator, an 
increase in the amount of time it takes to bring the body to a stop decreases the force 
requirements.  An example of this phenomenon would be walking on a compliant surface 
versus walking on concrete.   The compliant surface deforms and increases the amount of 
time it takes for the body to come to a stop.  This surface acts as an external device which 
increases the bodies shock absorption capabilities.  
At heel strike, there is an impact load that must be absorbed by the body.  Shock 
absorption can be quantified by measuring the impact loading rate during weight bearing 
activities such as walking.  The heel pad, ankle plantar flexion and knee flexion are the 
body’s natural shock absorbing mechanisms in the lower extremity.  People with knee 
OA tend to walk with a stiffer knee decreasing the shock absorption capabilities of the 
lower extremity.  Walking with a stiffer knee would seem to increase the amount of 
repetitive impact loading.  Animal studies support the significant role repetitive loading 
plays in the development and progression of knee OA.  A shock absorbing insole is an 
intervention which may decrease the amount of loading experienced by the knee during 
walking thereby altering pain and functional mobility deficits associated with knee OA.    
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 Shock absorbing insoles (SAI) placed inside the shoe are a potential external 
mechanism to increase shock absorption by decreasing the forces up the kinetic chain.    
When the foot hits the ground, the SAI deforms.  This material deformation increases the 
amount of time it takes for the body’s momentum to come to a stop.  This increase in 
time should theoretically decrease the forces acting up the kinetic chain.  An increase in 
the deformation time will decrease the loading rate.  A decrease in loading rate produces 
less force on the tibia and the more proximal joints.24   
 Biomechanical testing supports the shock attenuation theory of SAI.63  Significant 
differences in vertical GRF, time to peak impact force and impact loading rates were 
reported in healthy subjects ( n= 16) while wearing SAIs compared to wearing leather 
soled shoes.63   The researchers concluded that SAI could decrease the impact loading 
force by as much as 11%.         
 SAI Material Characteristics 
 Shock absorbing insoles made of a viscoelastic material are best suited to attenuate 
the repetitive forces during gait.55  A viscous material will allow slow, progressive 
deformation with an increase in loading which will allow the load to be dispersed on to a 
larger area,  thereby absorbing more energy.58  The deformation should happen slowly to 
prevent the material from bottoming out in which case, little energy would be absorbed.  
 Elasticity is another property that is important in the make up of an effective SAI.  An 
elastic material rebounds quickly to assume the original shape when the load is removed.  
A viscoelastic material combines the material property and will absorb forces with heel 
impact, yet rebound quickly to be ready for the next step.55  Finally, SAI should be 
 34 
comfortable so that individuals will wear them. Comfort has also been linked to a 
decrease in injury frequency in a group of military recruits.23           
 Literature on the Effectiveness of SAIs 
 SAIs have been used to prevent overuse injures and to improve comfort and 
performance in military recruits.23, 78, 79  Schewellnus et al78, randomly issued neoprene 
shoe inserts to 237 new military recruits to be worn with regular issue military boots.  
After nine weeks of basic training, the experimental group reported significantly less 
overuse injures to the lower leg and foot as compared to those who did not receive the 
inserts (n=1151).  Windel et al79, used a repeated measures design to compare four 
different types of soft shoe inserts worn in military boots.  A foot pressure measuring 
device placed in the shoe determined the pressures over selected areas of the plantar 
surface of the foot.  In this study, they concentrated on the heel pressures during heel 
strike while running.  They found all soft inserts used in this study significantly reduced 
heel pressures when compared to the “no insert” condition.   
 In another study, military recruits (n=103) reported significantly improved comfort 
when wearing soft insoles in their military boots as compared to the control group 
(n=103).23  A subset of these recruits (insert group = 34; control = 45) returned an injury 
assessment four months after beginning the study.  The frequency of foot, knee and low 
back pain was 1.5% to 13.4% lower for those wearing the inserts when compared to the 
control group.23Severity of injuries or the characteristics of the subset of participants 
were not reported.          
 There is some evidence to support the effectiveness of shock absorbing insoles in 
reducing lower extremity and back pain. Nursing students who regularly stood and 
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walked 8 – 10 hours per day were randomly divided into an insert (n=51) or control 
(n=49) group.  The insert group was asked to wear viscoelastic insoles while working.  
Both groups completed pain surveys at the end of the work day for a period of five 
weeks.  The insert group reported significant reductions in both the duration of post-work 
pain and the frequency of pain during work.25  
 There is also evidence to support the use of shock absorbing insoles to control foot 
motion.   It is standard practice to prescribe a rigid orthotic to control over pronation in 
the foot.80  Mcpoil and Cornwall 80 used a single subject design to compare the rearfoot 
and forefoot impulse while walking and running with both a rigid and shock absorbing 
insole in a 20 year old female with a history of excessive pronation and stress fractures in 
the foot and lower leg.  Impulse refers to the amount of vertical force acting over time 
and can be used as an indicator of shock attenuation.80  They reported that both during 
walking and running the shock absorbing insole significantly reduced the rearfoot 
impulse compared to the rigid orthosis.  They concluded that shock absorbing insoles 
should be considered when a reduction of forces is desired, even for persons with motion 
control issues.80  However, there was no follow-up to determine the  long term effects of  
SAI on lower extremity pain nor was there an assessment of foot kinematics.   
 Others have suggested that both motion control and shock absorption can occur with 
a SAI.  Eng & Pierrynowski81 investigated the use of SAI with rubber medial wedges 
placed in both the rear and forefoot on adolescent females complaining of patellofemoral 
pain and excessive pronation (n= 10).  They determined a SAI with medial posting 
significantly reduced knee frontal plane movement while walking.81  This was something 
that was previously considered only possible with rigid foot orthotics.   
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 Only one study was found investigating the effectiveness of SAI on persons with 
degenerative joint conditions.  Voloshin and Wosk 26 placed an accelerometer on the 
participant’s (n= 10, age range 16 – 45 years) tibial tuberosity with elastic straps to 
register bone vibration.  Participants walked with and without viscoelastic inserts at a 
controlled speed.  They reported a 42% reduction in shock waves when wearing the 
viscoelastic insert compared to shoes alone.  No mention was made of the location of the 
OA symptoms or radiographic evidence of severity.  The researchers concluded that 
viscoelastic inserts were effective artificial shock absorbers and issued them to patients 
(n=60) to investigate clinical improvement.  They issued SAI to patients with headaches, 
metatarsalgia, and knee pain (45%).  After 18 months of use, patients were reevaluated 
for clinical symptoms.  Seventy-eight percent of the subjects reported an abolishment of 
symptoms while 17% reported a satisfactory result.  The researchers concluded that SAI 
were an effective intervention to reduce shock waves on the musculoskeletal system in 
persons with degenerative joint disease.  This study, however,  has many limitations 
including a heterogeneous sample and lack of details on subjects and the method. 
Conclusions on the effectiveness of SAIs for subjects with knee OA cannot be made from 
this study  
 Summary of Literature   
 It is clear from the cited research that shock absorbing insoles have the capability of 
assisting in the attenuation of impact forces on the lower extremity during weight bearing 
activities.  A surprising lack of empirical evidence exists to document the effectiveness of 
SAI in persons with knee OA.  Most of the research testing the effectiveness of SAIs was 
 37 
either performed on healthy subjects or younger individuals with overuse injuries. .  
Individuals with knee OA are generally older and more sedentary individuals.     
 Shock absorbing insoles are currently a recommended intervention for persons with 
hip and knee OA to decrease pain.3, 21  Repetitive impulsive loading across the joints of 
the lower extremity is a recognized risk factor for the development and progression of 
knee OA.  Theoretically, SAI would seem to be an easy choice to decrease the 
attenuation of the vertical ground reaction forces.  Also they are inexpensive and are 
readily available to a vast majority of the public with knee OA.  The efficacy of SAI on 
this population is not known .   
 This study will fill a void in the literature by evaluating the effectiveness of a 
commercially available shock absorbing insole on knee pain, functional mobility and  
kinetics in persons with documented evidence and symptoms of knee OA. It is possible 
that some people may benefit more than others with the use of SAI.  This study also seeks 
to identify those participants who may maximally benefit from the use of SAIs.     
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Figure 2.1. Outline of the hypothesis of joint degeneration as described by Radin et al. 13 
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 CHAPTER 3 
METHODS 
Research Design:   
     This study was a quasi-experimental, one group, pretest posttest design.  The 
independent variable was shock absorbing insole. The outcome measures were knee pain 
after walking, functional mobility, and biomechanical characteristics of the lower 
extremity during walking.  
Subjects 
 Sixty community dwelling older adults were recruited by several different methods: a 
mass email was sent to the WSSU university faculty, staff and students; a newspaper ad 
was placed in the local Sunday paper; and flyers, informational sessions and word of 
mouth communication was used at local YMCA’s, churches and outpatient rehabilitation 
facilities.  A sample size of 60, determined a priori, provided 80% power to detect a 10 
mm change in the primary outcome measure (VAS Pain score) (Appendix A).    
Interested individuals were screened over the phone to determine whether they met the 
following inclusion criteria: 1) 50 years of age or older; 2) radiographic evidence of knee 
OA in the test extremity (K-L grading scale = 1 to  4); 3) Knee pain (WOMAC pain 
subscore of 4 or more and report moderate pain on at least 1 listed activity in the 
WOMAC) on most days82; 4) able to speak, write, and understand English; 5) able to 
walk 25 feet without an assistive device; 6) wear a shoe size available in the lab 
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(Women’s 6 – 10 and Men’s 8 – 14); and 7) able to attend two sessions of data collection 
within 14 days.  Individuals were excluded if they: 1) were currently wearing some type of 
foot orthosis (custom or over-the counter); 2) had lower extremity surgery of the test leg in 
the past 12 months; 3) had a total knee replacement on the involved leg; 4) had hip and/or 
ankle OA in the involved leg; or 5) had a neuromuscular disorder which affected their 
walking ability.   
 Participant Incentives:  Each participant received a free radiograph to properly stage 
knee OA severity.  At the completion of the study, each participant also received a pair of 
shock absorbing insoles and a pair of soft-sole brand socks used in the study.    
Instrumentation 
All data were collected in the Kate B. Reynolds (KBR) Human Performance Laboratory 
located in the FL Atkins Building on the campus of Winston Salem State University.  This is 
a 900 square foot research lab equipped with a ViconPeak gait analysis system with 8 
optielectric (60 Hz) cameras interfaced with an event and video control unit, AMTI force 
plate, and a Pentium 4 microcomputer equipped with a 250-gigabyte hard drive and VGA 
color monitor.  There was also a 7.3 meter raised walkway with two embedded AMTI force 
plates.  A photoelectric timing device interfaced with a digital timer (model 65301, Lafayette 
Instrument Co, Lafayette, Inc) was placed beside the walkway (4.2 meters apart) to 
accurately measure gait speed to the nearest .01 second.   
All participants wore the same type of shoe (Avia Cantilever, model 2051) and sock 
(Sofsole low cut) to control for the effects of variable shoe and sock types.  This decision was 
based on pilot testing where participants were allowed to wear their own “walking shoes” 
and socks during testing.   Frequently the shoe’s insoles were not removable and/or the heel 
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counter was not deep enough to accommodate the shock absorbing insole.  In addition, socks 
worn varied in thickness.  The lab shoe and socks worn in this study had identical 
construction for both men and women.  The shoes had an easily removable insole and a deep 
heel counter.  The midsole was made from compression molded EVA and featured a curved 
last which is designed to work with the curvature of the human foot to promote natural foot 
strike. Shoes were available in whole and half sizes (Men’s 8 – 14;  Women’s 6 – 10).  If a 
woman wore larger than a size 10, she was fitted with a man’s shoe. 
Shock absorbing insoles: The intervention in this study was an off-the-shelf shock 
absorbing insole (SofSole Athletes Plus, Implus Inc, Durham, NC) available in most athletic 
shoe stores, retailing for $19.99.  The insole is full-length with a curved last made of a type 
of closed cell foam called Implus XP.  Specific details of the composition of the Implus XP 
foam are propriety protected and unavailable  The SAI also has extra implus material at the 
heel (durometer reading of 60) and metatarsal area (durometer reading of 55) for added shock 
absorption.  This particular SAI was recommended by the manufacture for repetitive 
activities such as running and walking.        
Primary Outcome Measure 
The primary outcome measure was knee pain intensity, measured on a visual analog scale 
(VAS) after walking at a self-selected pace, fast pace and 6MWT.  The scale consists of a 
100 mm horizontal or vertical line (Appendix B) 41anchored with two descriptors :  “no pain” 
and  “worst imaginable pain”.  Participants were asked to rate their pain intensity by placing 
a single mark across the vertical line.  The distance from the “no pain” anchor to the mark 
placed on the line was measured and recorded.  This distance is the score and can range from 
0 to 100.  A higher score indicates more pain.  This measure has been tested with patients 
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suffering from both acute and chronic pain.  Concurrent construct validity has been reported 
as high as .95 when the VAS was compared to a numeric pain scale.42  In a study of ninety-
one patients with rheumatoid arthritis, the VAS pain scale had excellent test-retest reliability 
(ICC = .94).83  The minimum clinically significant difference on the VAS pain scale as 
reported by a group of subjects with temporomandibular pain was 28 mm.43   
Secondary Outcome Measure 
Several secondary outcomes were also assessed including gait speed, distance walked 
during the 6MWT, WOMAC, Arthritis Self-Efficacy Scale (ASES), and lower extremity 
kinetic data.  
Gait speed (GS) is the best measure of functional mobility.43 In this study both self-
selected and fast gait speed were assessed.  Testing takes less than 1 minute and is easily 
administered in a clinical or lab setting.  In a study investigating the reliability of gait speed 
in persons with knee OA, self-selected gait speed intrasession reliability (15 minute interval, 
ICC=0.94) and intersession reliability (1 week interval, ICC=0.95) was high.43  The 
photoelectric timing device measured the participant’s gait speed over the central 4.2 m to 
the nearest .01 second. Gait speed is generally reported in meters per second (m/s).    
 Six-minute walk test (6MWT).  Subjects were instructed to walk for 6 minutes and to 
cover as much ground as possible. The test is scored by measuring the distance traveled in 
meters.  Results of the 6MWT are significantly correlated to treadmill time and symptom-
limited maximal oxygen consumption (r = 0.52 and r = 0.53, respectively) and have a 3-
month test-retest reliability of 0.86.43 The test should ideally be conducted in a long 
corridor which minimizes turns.43  Participants in this study walked along a 300 foot 
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corridor (eight feet wide) located just outside the KBR research lab in the FL Atkins 
building.   
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The 
WOMAC is a widely used multidimensional, disease specific, self-report survey originally 
developed for people with hip and/or knee OA.52  It consists of 24 questions about joint pain, 
stiffness, and physical function (Appendix C).  Three subscores can be calculated with the 
maximum score of 20 for joint pain; 8 for joint stiffness, and 68 for physical function.  The 
subscores are generally reported individually.  For all of the subscores, higher scores indicate 
higher level of symptoms and/or disability.53  This survey can be completed in five to ten 
minutes keeping the participant burden low.43  Test-retest reliability for the pain subscales 
(.64 to .74) and the physical function subscales (.68 - .92) are good.53   
Arthritis Self Efficacy Scale (ASES).  The ASES is a self-administered disease-specific 
questionnaire consisting of 20 questions on the certainty with which different arthritis-related 
tasks are performed (Appendix D).  Questions are scored on a 10 point scale ranging from 1 
(very uncertain) to 10 (very certain). Three subscales scores  (10 – 100) physical function 
self-efficacy (FSE); pain management self-efficacy (PSE); and other symptoms self-efficacy 
(OSE) can be calculated by taking the mean of the subscale items.37  A higher score indicates 
higher self-efficacy (SE).  The questionnaire takes approximately 10 minutes to complete. 
Test-retest reliability of the ASES has been reported to be from .87 - .90 for the different 
scales.37  Pain SE and levels of clinical pain reported on the Arthritis Impact Scale are also 
moderately correlated (rho = .62).54 
Gait Analysis:  Three-dimensional kinematic gait data were collected using ViconPeak 
motion analysis system and software (ViconPeak Performance Inc, Denver, CO).  This 
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system uses eight infrared cameras recording at 60 Hz to capture the motion of the reflective 
markers which are placed on bony landmarks of the participant. Forces (Fx,Fy.Fz) and 
moments (Mx,My,Mz) were collected from AMTI (American Medical Technology Inc, 
Watertown, MA ) force plates embedded into the raised walkway and integrated with the 
motion capture system to allow simultaneous kinetic data collection at a sampling frequency 
of 600 Hz.  The raw analog data were amplified (gain = 4000 for all six channels), scaled to 
newtons and matched to the kinematic data.   
Infrared photoelectric timing device interfaced with a digital timer (model 65301, 
Lafayette Instruments, Los Angeles, CA) placed beside the walkway 4.2 m apart measured 
gait speed to the nearest .01 second.   
 Additional Measures:  Demographic information, a brief medical history, and current 
medications for knee OA were also obtained from each subject.  Demographic information 
(Appendix H) included contact information, gender, date of birth, marital and working status 
and level of education,  On the brief medical history form (Appendix I), participants 
indicated if they had been diagnosed and currently treated for any of the listed medical 
conditions.  If they had been diagnosed with any of the medical illnesses, they were asked if 
it limited their activities and, specifically, if it affected their walking ability.  They were also 
asked to indicate if they had ever undergone a total knee replacement.   The medication list 
(Appendix J) listed different classifications of common OA drug treatments including 
prescribed and over the counter medications.  Participants were asked to only check if they 
were currently taking that classification of drug.  Specific drug names or dosage was not 
recorded.   
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Procedures:   
Each participant received a radiological exam and completed two lab visits to minimize 
the effects of fatigue.  Please refer to Figure 3.1 for a pictorial representation of the testing 
protocol.  Eligible subjects were scheduled for the initial lab visit and asked to identify the 
most symptomatic knee for radiographic evaluation.  The primary investigator contacted the 
radiologist with the participant’s date of birth and involved leg and received a physician’s 
referral for the radiographs via fax.  Participants were sent letters verifying the date and time 
of the first lab visit. The letter also contained directions to the facility and a parking pass for 
the WSSU campus. 
Lab Visit 1:   
The study was explained to the participants and they completed an informed consent 
prior to any data collection.  Participants then completed the following forms:  ,  
demographic, medical history, medication list, the WOMAC questionnaire, and the ASES.  
Participants were then oriented to the lab equipment and anthropometric measurements 
necessary for the biomechanical gait analysis were taken and recorded.  The participant was 
then fitted with a pair of lab walking shoes and socks and given the opportunity to 
accommodate (approximately 10 minutes) to walking in those shoes.   
 Participants then completed both the self-selected gait speed test and the fast gait speed test 
(in that order) under both conditions (with and without SAI). The order the conditions were 
tested was randomly determined prior to the visit. The testing ended with the 6MWT under 
one of the SAI conditions (randomly chosen). Details of the procedures for each of the 
functional mobility tasks are as follows:  
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1)   Self Selected Gait Speed:    Participants walked down a raised 7.3 meter walkway.  The 
photoelectric timing device interfaced with a digital timer was set up in the central 4.2 meters 
of this walkway.  This method of only measuring the central portion of the walkway ensured 
the participant was neither accelerating nor decelerating.   The timing device was placed on 
tripods at the beginning and end of the capture area so that the beam was at the level of the 
participant’s pelvis.  Participants completed two trials of walking at their self-selected speed 
and the time elapsed was recorded to the nearest .01 second.  The distance (4.2m) was divided 
by the elapsed time (sec) to determine gait speed (m/sec).  Participants rated their pain 
intensity on the VAS after completing both trials.  Refer to Appendix K for data collection 
form. 
2)  Fast Gait Speed:     Participants were also asked to complete two trials walking “as fast 
as you safely can” along the same 7.3 meter walkway.  The timing device was again utilized to 
determine the time it took to walk the central 4.2 m recorded to the nearest .01 seconds.  
Results of the two trials were averaged and reported in meters/second.  After completing both 
trials, participants rated their pain intensity on the VAS.  Refer to Appendix K for data 
collection form. 
3)  Six Minute Walk Test:   A 300 foot hallway located just outside the KBR lab was used 
for this test.  This hallway was marked with tape every twenty-five feet.  The subject’s resting 
blood pressure was measured.  Participants with a resting blood pressure of 200 systolic or 110 
diastolic, were not allowed to complete this test.  Participant’s were asked to “cover as much 
ground as possible” by walking back and forth along the walkway for six minutes. The tester 
recorded the number of hallway laps completed.  At the end of six minutes, the participant 
stopped and the tester marked the position of the participant on the floor with tape.  The tester 
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then measured the distance from the nearest twenty-five foot marker to the place where the 
participant stopped.  This distance was added to the known distance walked (one lap = 91.4 
m).  Participants rated their pain intensity on the VAS after completing the six minute walk.  
Refer to Appendix K for data collection form. 
 After completing the functional mobility tasks, the participant was given the radiograph 
referral and directions to the Comprehensive Rehabilitation Plaza in Winston-Salem, NC 
where the radiographs were performed.   
Radiographic Screening  An anterior-posterior weight-bearing knee x-ray was used to 
identify tibiofemoral arthritis. The participant’s knee was flexed to 15 degrees, and the beam 
was centered on the joint space.  The minimum joint-space width of the knee was measured 
using a 0.1 mm graduated magnifying lens to assess disease progression.  Severity of 
tibiofemoral OA was measured using the K-L grading scale (Grade 0 – 4).29 The literature 
supports excellent intrarater reliability with severity scores (ICC = .88 - .91).84  Participants 
with a K-L grading scale of 1 – 4 were eligible for this study. 
A standing full length weight-bearing x-ray was used to determine mechanical hip-knee-
ankle (knee varus/valgus) angle.  The participant stood with equal weight on both lower 
extremities without footwear, positioned so that the tibial tubercles faced forward and the 
midheel and second digit of each foot are aligned with pieces of tape placed perpendicular to 
the frontal plane.  The x-ray beam was centered on the test knee at a distance to allow 
visualization of the hip and foot. Depending on limb size, a setting of 100-300 milliampere-
seconds and a kilovoltage of 80-90 was used.  The physician measured the mechanical hip-
knee-ankle angle to determine the amount of knee malalignment.  The mechanical axis refers 
to the angle formed by a line drawn from the center of the femoral head to the center of the 
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tibial spine and a line drawn from the tibial spine to the center of the ankle joint.  Hip-Knee-
Ankle angles greater than 180 degrees were in a valgus position while angles less than 180 
degrees were in a varus position.85  Intrarater reliability of radiographic measurement of the 
mechanical axis of the knee is very good (ICC = .98 - .99).86  
The primary investigator transported all radiographic films (identified only by subject ID) 
from the Comprehensive Rehab Outpatient Center (Winston-Salem, NC) to Dr. Jordan 
Renner MD (Associate Professor, Radiology, UNC-CH School of Medicine) who was the 
primary radiograph reader.  Each set of films were accompanied with a data form (Appendix 
L) .  Dr. Renner completed the data forms and returned them to the primary investigator.     
Lab Visit 2:   
The second lab visit was scheduled within 14 days of the first lab visit. To confirm that 
pain levels were comparable between visits, the WOMAC pain subscale was administered 
again at the second visit.  The 6MWT was repeated with or without the SAI as was 
determined in the initial visit.  Participants then completed the biomechanical gait analysis.   
Procedure for Gait Analysis:   Gait analysis was only performed using a self-selected 
speed.  Subjects changed into standardized test clothing (black shorts and top) and reflective 
markers were placed (using the modified Helen Hayes Marker Set) on the following body 
parts:  sacrum, bilateral ASIS, mid thigh using a wand, lateral epicondyle of the femur, tibia 
using a wand extender, lateral malleolus, heel marker, and 2nd head of metatarsal (modified 
from originally described marker set).  The marker placement modification was required by 
ViconPeak to better integrate with their software.  An extra marker was also placed on the 
anterior right thigh to easily identify the right leg.  Subjects completed 6 acceptable walking 
trials at their self-selected walking speed under each condition (with and without SAI).  An 
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acceptable trial was defined as a trial which the participant’s entire foot was placed on the 
force plate and all markers were visible throughout the trial.  The order of the testing (with 
and without the SAI) was completed in the same order as the functional mobility testing.  
Subjects were allowed an accommodation period of 10 minutes between conditions and were 
allowed to rest between trials as needed. 
Data Reduction:   
 Self selected gait:  Gait speed was averaged over the two trials for each condition (self-
selected and fast) and recorded as the average self selected gait speed with (SSGSI) and 
without (SSGSN) the SAI.  The VAS scales were measured to the nearest millimeter for each 
condition and recorded. 
 Fast gait:  The gait speed recorded for the fast walking trials under each condition (with 
and without SAI) were averaged together and recorded as the average fast gait speed with 
SAI (FGSI) and without the SAI (FGSN).  The VAS scales were measured to the nearest 
millimeter for each condition and recorded. 
 Six Minute Walk:  The distance walked to the nearest inch with the SAI (6MWI) and 
without the SAI (6MWN) was recorded and converted to meters.  The VAS scales completed 
after each condition were measured to the nearest millimeter and recorded. 
Gait analysis:  Operational definitions: Initial contact was determined by the first time 
point when the vertical ground reaction force (VGRF), as measured by the force plate, 
exceeded zero. Loading response began at initial contact and ended when the VGRF reached 
the peak force during the weight acceptance curve of the ground reaction force curve (Figure 
3.2).  The rate of loading was determined by dividing the peak VGRF of the weight 
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acceptance curve by the time it took to reach that peak (LR = peak VGRF/time to peak 
VGRF).  
Gait analysis data reduction:  All kinetic data were reduced and analyzed using the Peak 
Motus KineCalc software version 8.0 (ViconPeak Performance Inc, Denver, CO).  Raw 
kinematic data under each condition were filtered using 4th order Butterworth low pass digital 
filter with a cut off frequency of 6 Hz.87  The smoothed coordinate data, GRF, gravitational 
and inertial forces served as input to an inverse dynamics model to calculate selected 3-
dimensional knee external moments.  Refer to Appendix E for detailed calculations.  Each 
individual selected trial was time normalized to the stance phase of the gait cycle.  Refer to 
Appendix F for gait analysis data collection form.  Previous pilot testing confirmed reliability 
of these measures (Appendix G).  
Three out of six trials under each condition were chosen for data analysis.  Only trials 
with GS within + 3.5% of self-selected walking speed were used for data reduction.  
Outcome variables were recorded from each of the selected three trials and then averaged 
together for each condition (with and without SAI) for further data analysis.   
Peak vertical ground reaction forces (Fz) were normalized to body weight (N) to make 
valid comparisons across subjects.  Kinetic variables included loading rate during loading 
response; time to peak VGRF, peak VGRF, peak external knee flexor moment and average 
sagittal plane knee moment during loading response of stance. The external peak knee flexor 
moment during the loading response of gait and the averaged external  knee moment during 
loading response were normalized by the product of body mass and height (kg*m).88  
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Data analysis:   
Separate one-way, within subject repeated measures ANOVA’s were conducted to 
determine the effect of SAI on each of the outcome variables. Shock absorbing insoles was 
the within subject factor with 2 levels (with and without SAI).  Separate one-way, within 
subject repeated measures ANCOVA’s were conducted to determine whether subject 
characteristics (e.g., weight, OA severity, etc.) modified the effects of SAI on knee pain after 
completing the 6MWT.  To further explore the data, we performed post hoc analysis by 
computed pain change scores reported during the 6MWT both with and without the SAI 
(pain without SAI – pain with SAI).  Negative numbers indicated a decrease in pain.  We 
determined quartiles for each variable and used the participants in the lowest and highest 
quartiles for comparison using an independent sample t-test with the change scores in 6MWT 
as the dependent variable.  We used an ANOVA when more than two groups were to be 
compared.  All tests were 2-sided with the alpha level set at .05. All analyses were conducted 
using SPSS ver 15.   
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Figure 3.1.  Summary of Data Collection 
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Figure 3.2.  Typical ground reaction force during stance phase of walking at self-selected 
speed.  Peak VGRF and time to peak VGRF during load acceptance phase of stance is 
identified.  Stance is shown in percent time. 
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RESULTS 
 
 Ninety-four individuals were screened via telephone. Sixty-nine participants met all 
criteria and were invited to participate in the study.  Four participants dropped out of the 
study prior to getting the required x-ray.  The reasons for the participant dropout varied: one 
person fell and broke his hip; one person an unexpected trip for an extended period; two 
people dropped out for unknown reasons.  Five participants were excluded secondary to lack 
of radiographic evidence of knee OA.  The final sample consisted of 60 community-dwelling 
senior adults (23 males, 37 females).  Participant demographic descriptive information is 
listed in Table 4.1 and 4.2. 
The dependent variables were knee pain, gait speed, distance walked and kinetic 
variables which occurred during loading response of the stance phase of gait.  All kinetic 
variables of interest occurred during loading response of the stance phase of the gait cycle.  
Kinetic variables included time to peak vertical ground reaction force (VGRF), peak VGRF, 
loading rate, peak and average sagittal plane external knee moment.   The independent 
variable was shock absorbing insoles (SAI).  Comparison of baseline WOMAC pain 
subscores (table 4.1) for the two testing days did not reveal a significant  difference (t60 = 
1.043, p = .301).   
All functional mobility outcome variables and pain measures were within two standard 
deviations of the mean, therefore, all data (n = 60) for these variables were used in the data 
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analysis.  Data from the gait analysis were not analyzed for two subjects secondary to camera 
malfunction during data collection.  Of the remaining participants (n = 58), moment data 
were unavailable for one person.  Therefore, analysis of force plate data was conducted on all 
58 participants, while analyses on moment data were conducted on only 57 participants.  
Apriori alpha levels were set at p < .05 for all analyses.   
Two participants reported having a total knee replacement (TKR) on the non-tested limb..  
Only a few characteristics differed from the group mean.  They had a higher BMI (36.3 and 
40.9), walked at a slower self-selected speed (.98 m/sec, and .75 m/sec) and walked a shorter 
distance on the 6MWT (303.9 m and 296.8 m).  All other variables were very close to the 
group mean.  Analyses were conducted both including and excluding the data from these two 
individuals.  Although the means and significance levels changed slightly, there was no 
change in the outcomes on any variable (Appendix M).  Therefore, data reported include all 
participants.       
Aim 1 – Pain and Functional Mobility Outcome Measures 
 Knee pain was the primary dependent variable (Table 4.3, Figure 4.1).  Participants 
reported significantly less pain after walking six minutes while wearing the SAI (26 + 25.7 
mm) as compared to shoes alone (31.4 + 28 mm, F1,59 = 5.067, p = .028).  Effect size (ES) 
was small (.079) while power (1-β) estimates were moderate (.60).  No significant 
differences were found when comparing the participants who reported a decrease in pain 
(57%, n = 34) while wearing the SAI compared with those who actually reported an increase 
in pain (32%, n = 19).  Post hoc t-test performed on these two groups revealed no differences 
in age, BMI, number of comorbidities, initial WOMAC pain subscore, or ASES pain 
subscore (table 4.4).  A higher percentage of retired people (35%) and those with a college 
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degree (53%) reported a decrease in pain while wearing the SAI compared to those who 
reported an increase in pain (16% retired; 47% college).   
There were no significant differences in knee pain while walking with or without the SAI 
during self selected walking speed (F1,59 = 0.26, p = .873, ES < 0.001, 1-β = .053), or fast 
walking speed (F1,59 = 3.611, p = .062, ES = .058, 1-β = 0.464).    There were no significant 
differences in functional mobility outcome measures when wearing the SAI as compared to 
not wearing the SAI (table 4.5, figure 4.2).  Specifically, no statistical differences were found 
in self selected gait speed (F1,59 = .032, p = .859, ES = .001, 1-β = .054) or fast gait speed 
(F1,59 = .792, p = .377, ES = .013, 1-β = .141).   Likewise, there was no difference in the 
distance walked (table 4.5, figure 4.3) during the six minute walk while wearing the SAIs 
compared with not wearing the SAIs (F1,59 = 1.105, p = .297, ES = .018, 1-β = .179). 
Based on these findings the use of SAI appeared to decrease pain when a person with 
symptomatic knee OA walked for a sustained period of time (e.g. 6 minutes).  However, the 
use of SAI did not influence pain during shorter walking distances at either the slow or fast 
walking speed.  The use of a SAI did not change self selected walking speeds, allow faster 
walking speeds, or allow more distance to be covered during a timed walking test.   
 Aim 2: Biomechanical Outcome Measures 
There were no significant differences in the biomechanical outcome measures that 
occurred during loading response (heel strike to time of peak vertical ground reaction force) 
while wearing SAIs versus shoes alone (table 4.6, figure 4.4, 4.5, 4.6).  There were no 
significant differences in the time to reach peak VGRF (F1,57 = .343, p = .560, ES = .006, 1-β 
= .089), peak VGRF during loading response  (F1,57 = 2.648, p = .109, ES = .044, 1-β = .360) 
or loading rate (F1,57 = .486, p = .489, ES = .008, 1-β = .105) between the two conditions.   
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 Knee external moments occurring in the sagittal plane during the loading response were 
analyzed between both conditions (table 4.6, figure 4.7). The peak external moment  was not 
significantly different between the two conditions (F1,56 = .020, p = .887, ES <.001, 1-β = 
.052 ).  The average external moment during this time frame was also not significantly 
different between the two conditions (F1,56 = .848, p = .361, ES = .015, 1-β = .148).  The 
kinetic variables most closely associated with an increase in shock absorption were not 
changed with the use of a SAI during self-selected walking speeds.     
Aim 3 – Do Subject Characteristics Modify The Effects of SAIs? 
 Physical characteristics of participants were used as covariates when comparing pain 
recorded after the six minute walk test (6MWT) for both conditions (table 4.7).  One 
participant was unable to complete the ASES and was excluded from analysis on that 
outcome variable only.  There were no significant interactions with SAI and participant 
weight (F1,58 < .001, p = .987, ES < .001, 1-β = .050), knee OA severity (F1,58 = 1.185, p = 
.281, ES = .020, 1-β = .188), or hip-knee-ankle angle (F1,58 = .059, p = .809, ES = .001, 1-β = 
.057).   The baseline pain (WOMAC pain subscore) did not modify the effects of SAI (F1,58 = 
.843, p = .362, ES = .014, 1-β = .147).  The ASES pain subscore also did not have an 
interaction effect with the SAI (F1,57 = 2.670, p = .108, ES = .045, 1-β = .362),  
Post hoc analysis examining the five variables we most suspected to modify the effects of 
SAI on pain reduction (weight, knee OA severity, initial pain, knee malalignment, and self-
efficacy) during the 6MWT revealed no significant differences between participants in the 
lowest and highest quartiles for each of the targeted characteristics (table 4.8).    
Heavier people (range 102.2 – 141kg., n = 15) reported a larger decrease in pain (2.4 + 
21.1 mm) versus lighter weight participants (range 54 – 72.8kg, n=15, change in pain = .2 + 
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12.2 mm, 4.67, t28 = .414, p = .682, figure 4.8).  People with less severe knee OA (K-L grade 
1, n=20) reported a larger decrease in pain (9 + 18.1 mm) while wearing the SAI compared to 
those with a K-L grade 4 (4.1 + 20.3 mm, n = 13, t31 = -.725, p = .474 , figure 4.9).    
We hypothesized participants with less pain as measured by the WOMAC pain subscore 
would report less pain during the 6MWT while wearing the SAI.  Since no significant 
differences were found between the two WOMAC pain subscores on the two different testing 
days, only the initial WOMAC pain subscore (range 4 – 20) was used in the post hoc 
analysis. Participants with a high initial WOMAC pain subscores (range = 10 – 17, n = 16) 
reported a larger decrease in pain when wearing the SAI (15.4 + 17.5 mm) as compared to 
participants with a low initial WOMAC pain scores (range 4 – 6, n=21, decrease in pain = 
4.7+ 15.5 mm, t35 = 1.972, p = .057, figure 4.10).    
Participants with a varus alignment (n = 41) reported the greatest decrease in pain while 
wearing the SAI (6.6 + 20.3 mm) versus those with a valgus alignment (4.3 + 11.3 mm, n = 
13) or those with neutral alignment (1 mm, n = 6).  No significant difference were found 
between the groups (F2,57 = .463, p = .632, figure 4.11).  Participants with a mild varus knee 
angle (<3 degrees, n= 18) reported a greater decrease in pain (8.5 + 22.4  mm) when wearing 
the SAI during the 6MWT as compared to those with a more severe varus angle of the knee 
(> 7 degrees, n = 15, decrease in pain = 6 + 20.9 mm).   However, no significantly difference 
was found (t31 = .326, p = .747, figure 4.12).  There were fewer persons with valgus 
alignment (n = 13), however, the same pattern was still present.  Those with mild valgus (< 
2.5 degrees, n = 3) reported a larger decrease in pain (10.6 + 19.4 mm) compared to those 
with more severe valgus (> 5 degrees, n = 4, decrease in pain = 5 + 8.1 mm).   
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Those who reported a higher level of self efficacy (ASES score > 78, n=16) only reported 
a very small decrease in pain (1 + 18.5 mm) during the 6MWT when wearing the SAI.  In 
contrast, those with lower ASES score regarding pain (n = 16, ASES score < 52) reported a 
much larger decrease in pain (12.3 + 20.1 mm, figure 4.13).  However, the difference 
between these two groups was not significant (t30 = -1.641, p = .111).  
In summary, no significant interactions were detected between the pain reported while 
walking and any of the listed covariates.  Post hoc analyses suggests that participants who 
were heavier, had mild malalignment, higher level of initial pain and lower pain self-efficacy 
benefited more from the SAI.    
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Table 4.1.  Participant (n = 60) demographic information (mean, standard deviation and 95% 
confidence interval). 
 
 
 
  Mean SD 95% CI Frequency; Percentage 
 
 
Age   
(years) 
 
 
63.9 
 
8.8 
 
61.6 – 66.2 
 
 
BMI  
(Kg/m2) 
 
 
31.9 
 
7.1 
 
30.1 – 33.7 
 
 
Comorbidities 
 
 
1.6 
 
1.5 
 
1.2 – 2.0 
55%  - High Blood Pressure  
23%  - Diabetes 
33% -  Low Back Pain 
 8% -   Heart Disease 
 
Number of 
Medications for 
OA 
 
 
1.7 
 
1.1 
 
1.4 – 2.0 
 
 
Knee OA 
Severity Rating 
(K-L scale) 
 
2.47 
 
1.2 
 
2.16 – 2.77  
 
Grade 1 (n = 19; 32%) 
Grade 2 (n = 8; 13%) 
Grade 3 (n = 19; 32%) 
Grade 4 (n = 14; 23%) 
 
 
WOMAC pain 
score (4 – 20) 
Baseline 1 
 
 
7.77 
 
2.8 
 
7.05 – 8.49 
 
 
WOMAC pain 
score (4 – 20) 
Baseline 2 
 
 
7.47 
 
2.8 
 
6.7 – 8.19 
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Table 4.2.  Participant (n = 60) demographic information (frequency and percentages). 
 
 Frequency; Percentage 
 
 
Gender 
 
 
Males (n = 23; 38%)  
Females (n = 37; 62%) 
 
 
Race 
 
White (n = 38; 63%) 
Black (n = 20; 33%) 
American Indian (n = 2; 3%) 
 
 
Social Status 
 
Married (n = 41; 68% ) 
Divorced (n = 11; 18%) 
Widowed (n = 8; 13%) 
 
 
Highest Level of 
Education 
 
Some High School (n = 3; 5%) 
High School (n = 11; 18%) 
Some College (n = 9; 15%) 
Associates Degree (n = 7; 12%) 
Bachelor’s Degree (n = 11; 18%) 
Postgraduate Degree (n = 19; 32%) 
  
 
Work Status 
 
Working Full Time (n = 24; 40%) 
Working Part Time (n = 8; 13%) 
Retired (n = 17; 28%)  
Unemployed ( n = 2; 3%) 
Homemaker (n = 5; 8%) 
Disabled/ Unable to work (n = 4; 7%) 
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Table 4.3.  Participant (n = 60) VAS Scores (mm) indicating amount of knee pain during walking tasks while wearing the SAI and 
without the SAI.  *Indicates significance difference (p < .05). 
 
 
 With SAI Without SAI     
Dependent 
Variable Mean SD 95% CI Mean SD 95% CI 
 
F-value 
 
p-value 
 
ES 
 
Power 
 
VAS Pain Scale 
(mm):  
Self Selected 
speed 
15.7 
 
 
 
13.7 
 
 
 
12.1 - 19.1 
 
 
 
15.4 
 
 
 
 
17.6 
 
 
10.8 – 19.9 
 
0.026 
 
0.875 
 
<.001 
 
.053 
 
VAS Pain Scale 
(mm):  
Fast speed 
 
18.0 
 
 
16.4 
 
 
13.7 - 22.2 
 
 
22.0 
 
 
23.5 
 
 
15.9 - 28.0 
 
 
 
3.611 
 
 
0.062 
 
0.058 
 
0.464 
 
VAS Pain Scale 
(mm): 
Six-Minute Walk 
26.1 
 
 
25.7 
 
 
19.4 - 32.7 
 
 
31.4 
 
 
28 
 
 
24.1 - 38.6 
 
 
 
5.067 
 
0.028* 
 
0.079 
 
.60 
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Figure 4.1. Effect of Shock Absorbing Insole (SAI) on Visual Analog Scores (VAS) for 
pain during Self Selected Gait, Fast Gait, and Six-Minute Walk Tests.   
* Indicates a significant decrease in VAS during the Six-Minute Walk Test 
With SAI compared to the Without SAI condition (p < 0.05). 
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Table 4.4.  Comparison of participants who reported a decrease in knee pain (n=34) while walking with the SAI versus those who 
reported an increase in pain (n=19).   Change score means (pain during 6MWT without SAI – pain during 6MWT with SAI), standard 
deviations and t-test results for each of the characteristics tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†Western Ontario McMasters Arthritis Index pain subscore.   §Arthritis Self-Efficacy Pain subscore. 
 
 Reported 
decrease in pain 
(n=34) 
 
Reported 
increase in 
pain 
(n=19) 
 
Characteristic Mean 
 
SD 
 
Mean 
 
SD t-value p-value 95% CI of  
the difference 
 
Change Score 
 
-16 
 
14.9 
 
11.8 
 
 
13 
 
-6.8 
 
* <.001 
 
-40 – 19.6 
Age 
 
63.9 
 
9.7 
 
63.4 
 
8.4 .212 .833 
 
-4.8 – 5.9 
BMI 
 
31.8 6.4 33.2 8.6 -.683 .498 -5.6 – 2.8 
Comorbidities 1.65 1.5 
 
1.21 
 
1.3 1.063 .293 
 
-.388 – 1.3 
Initial WOMAC Pain 
subscore† 
8.3 
 
3 
 
7.6 
 
2.7 .891 .377 
 
-.9 – 2.4 
ASES Pain subscore§ 
 
61.9 20.2 66.1 14.5 -.804 .425 -14 – 6.4 
Distance walked 
without SAI 
 
438.9 125.1 468.1 101.6 -.869 .389 -96.7 – 38.3 
Distance walked  
with SAI 
453.5 130.5 453.4 87.6 .003 .997 -67.3 – 67.5 
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Table 4.5.  Participant (n = 60) functional mobility measures walking with and without the SAI. 
 
 
 With SAI Without SAI     
Dependent  
Variable Mean SD 95% CI Mean SD 95% CI 
 
F-value 
 
p-value 
 
ES 
 
Power 
 
Self-selected  
Gait Speed 
(m/sec) 
 
1.06 
 
 
 
.27 
 
 
 
 
.99 – 1.13 
 
 
 
 
1.06 
 
 
 
 
.25 
 
 
 
.99 – 1.12 
 
0.032 
 
0.859 
 
0.001 
 
0.054 
Fast Gait Speed 
(m/sec) 
1.42 
 
 
 
.33 
 
 
 
1.34 – 1.51 
 
 
 
1.45 
 
 
 
.35 
 
 
 
1.36 – 1.53 
 
 
 
0.792 
 
0.377 0.013 0.141 
Distance walked 
during 6MWT 
(meters) 
450.7 115.3 
 
 
 
420.9 – 480.5 
 
 
 
441.7 
 
 
 
126.9 
 
 
 
408.9 – 474.4 
 
 
 
1.105 
 
0.297 0.018 0.179 
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Figure 4.2. Effect of Shock Absorbing Insole (SAI) on gait speed for self-selected and 
fast walking mobility tasks. 
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Figure 4.3.  Effect of Shock Absorbing Insole (SAI) on the distance walked during the Six-
Minute Walk Test.   
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Table 4.6.  Biomechanical outcome measures (n=58) during walking at self-selected walking speeds both with and without SAI.   
 
 
 With SAI Without SAI     
Dependent 
Variable Mean SD 95% CI Mean SD 95% CI 
 
F-value 
 
p-value 
 
ES 
 
Power 
 
Time to peak 
VGRF  
(sec) 
 
.198 
 
 
 
.057 
 
 
 
.183 – .213 
 
 
 
.200 
 
 
 
 
.064 
 
 
 
.183 – .216 
 
 
0.343 
 
0.560 
 
0.006 
 
0.089 
Peak VGRF 
(times BW) 
 
1.08 
 
 
.09 
 
 
1.06 – 1.11 
 
 
1.07 
 
 
.09 
 
 
1.05 – 1.10 
 
 
2.648 
 
.109 0.044 0.360 
Loading Rate 
(times BW/sec) 
 
5.94 
 
1.87 
 
5.45 – 6.43 
 
5.87 
 
1.79 
 
5.4 – 6.34 
 
0.486 0.489 0.008 0.105 
Peak Knee 
Moment†  
(N/BW*HT)   
 
-.174 
 
 
.157 
 
 
-.215 - -.132 
 
 
-.175 
 
 
.143 
 
 
-.213 - -.137 
 
 
0.020 .887 <.001 .052 
Average Knee 
Moment† 
(N/BW*HT) 
 
-.012 
 
 
.093 
 
 
-.037 - -.013 
 
 
-.018 
 
 
.082 
 
 
-.039 - .004 
 
 
0.848 0.361 0.015 0.148 
 
†External sagittal plane knee moment (n= 57) during loading response of stance.  Negative number indicates flexion moment. 
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Figure 4.4. Effect of Shock Absorbing Insole (SAI) on time to peak VGRF during self-
selected walking speeds 
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Figure 4.5. Effect of Shock Absorbing Insole (SAI) on peak vertical ground reaction force 
(VGRF) during self-selected walking speeds.  Ground reaction force is 
normalized to body weight in newtons.  
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Figure 4.6. Effect of Shock Absorbing Insole (SAI) on Loading Rate during self-selected 
walking speeds.  Loading Rate was calculated using the normalized peak 
VGRF/time to peak VGRF.    
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Figure 4.6. Effect of Shock Absorbing Insole (SAI) on external sagittal plane knee 
moments during loading response of the stance phase of gait while walking at 
self-selected speeds.  Moments were normalized to the product of body weight 
* height.  All moments listed are external knee flexion moments.    
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Table 4.7.  Analysis of covariance interaction results with pain reported during 6MWT.       
 
 
 
Covariate 
 
 
F-value 
 
p-value 
 
ES 
 
Power 
 
Body Mass 
 
 
<0.001 
 
.987 
 
<0.001 
 
0.05 
Knee OA 
severity 
 
1.185 
 
.281 0.020 0.19 
HKA angle† 
 
.059 .809 0.001 0.06 
WOMAC 
initial pain‡   
.843 .362 
 
0.014 .147 
ASES pain 
subscore§ 
 
2.670 .108 .045 .362 
 
 †Mechanical hip-knee-angle angle. 
 ‡Western Ontario McMasters Arthritis Index pain subscore. 
 §Arthritis Self-Efficacy Pain subscore 
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Table 4.8.  Change score means (pain during 6MWT without SAI – pain during 6MWT with SAI), standard deviations and t-test 
results for each of the covariates using the 1st and 4th quartile as group cut points.  Negative numbers indicate decrease in pain.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†Mechanical hip-knee-angle angle. ‡Western Ontario McMasters Arthritis Index pain subscore. §Arthritis Self-Efficacy Pain subscore 
 
 Mean change 
in  
VAS  
 25th quartile 
Mean change 
in VAS  
 75th quartile 
  
Covariate n 
(1st/4th) 
Mean 
 
SD 
 
Mean 
 
SD t-value p-value 95% CI of  
the difference 
 
Body Mass 
 
 
15/15 .2267 
 
12.22 
 
-2.14 
 
 
21 
 
.414 
 
.682 
 
 
-10.3 – 15.5 
Knee OA 
severity 
 
20/13 -9 
 
18.1 
 
-4 
 
20.4 -.725 .474 
 
-18.7 – 8.9 
HKA angle† 
Varus 
 
18/15 -8.5 
 
 
22.4 
 
 
-6 
 
 
20.9 .326 .747 
 
 
-13 - 18 
HKA angle† 
Valgus 
3/4 -10.6 
 
19.4 
 
-5.6 
 
8.1 -.518 .627 
 
-32.5 – 21.6 
WOMAC 
initial pain‡ 
 
21/16 -4.7 
 
15.5 
 
-15.4 
 
17.5 1.972 .057 
 
-.32 – 21.8 
ASES pain 
subscore§ 
 
16/16 -12.3 
 
20.1 
 
-1.1 
 
18.5 -1.641 .111 
 
-25.2 – 2.7 
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Figure 4.8. Effect of Shock Absorbing Insole (SAI) on knee pain change scores as 
measured on the Visual Analog Scores (VAS).   
Change scores = VAS without SAI – VAS with SAI. 
Negative number indicate a decrease in pain.    
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Figure 4.9. Effect of Shock Absorbing Insole (SAI) on knee pain change scores during the 
six-minute walk test as measured on the Visual Analog Scores (VAS).   
Change scores = VAS without SAI – VAS with SAI.  Scores indicate a 
decrease in knee pain when wearing SAI. 
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Figure 4.10. Effect of Shock Absorbing Insole (SAI) on knee pain change scores as 
measured on the Visual Analog Scores (VAS).   
Change scores = VAS without SAI – VAS with SAI. 
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Figure 4.11. Effect of Shock Absorbing Insole (SAI) on knee pain change scores as 
measured on the Visual Analog Scores (VAS) on people with different HKA 
alignment.  Change scores = VAS without SAI – VAS with SAI. 
 Negative scores indicate a decrease in pain. 
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Figure 4.12. Effect of Shock Absorbing Insole (SAI) on knee pain change scores as 
measured on the Visual Analog Scores (VAS) on people with mild or severe 
varus or valgus malalignment.  Change scores = VAS without SAI – VAS 
with SAI. 
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Chapter 5 
 
Discussion 
  
Primary Outcome: Effects of SAI on Knee Pain  
The primary outcome for this investigation focused on the immediate effects of shock 
absorbing insoles (SAI) on knee pain in persons with symptomatic knee OA.  The primary 
finding was a significant decrease in knee pain during the 6MWT when wearing SAIs.  No 
differences were found in knee pain during shorter walking tasks, functional mobility 
measures or kinetic variables.     
 Our primary hypothesis was that knee pain would diminish when wearing the SAI during 
functional walking tasks.  Our data did not support this hypothesis for either the self-selected 
walking or fast walking tasks.  Participants reported almost identical knee pain on the VAS 
(change score = .26) when walking with and without the SAI at a self-selected speed. The 
literature suggests that people with knee OA choose a self-selected walking speed which 
minimizes pain.51  This would explain the low amount of pain reported for the self-selected 
walking speed condition.  It is possible that the pain measure had a floor effect for the SAI 
condition when walking at the self-selected pace due to subjects walking at a speed that 
already minimized their pain.   
To our knowledge, this is the first study which evaluated pain during walking a short 
distance immediately after placement of a shock absorbing insole.  Thus, we cannot directly 
compare our findings to previous research.    All other studies reporting pain, used the 
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WOMAC pain subscore to evaluate knee pain over the last forty-eight hours.51, 69   
Participants reported more pain when walking at a fast pace both with and without the 
SAI compared to walking at a self-selected speed (table 4.3).  The higher pain during fast 
walking was an expected outcome because faster walking causes a higher ground reaction 
force which in turn increases the forces on weight-bearing joints89 and results in increased 
knee pain.90 When walking at the fast speed, participants reported less pain walking with the 
SAI; however, this decrease in pain was not significant (p = .062).  Greater variability of pain 
values while walking with and without the SAI at the fast pace suggested the change in pain 
varied more among participants than during the self-selected speed.  The increased variability 
in pain values during the fast walking conditions may have decreased our statistical power 
(1-Β = .47) and limited the ability to detect a significant decrease in pain while wearing the 
SAI during fast walking conditions.       
It is reasonable to assume that those who walked faster at either the self-selected or fast 
walking speed may have experienced more pain and therefore had a different outcome with 
the SAI.  To further investigate potential factors that may have influenced the lack of a 
significant decrease in pain when walking at a self-selected speed we investigated the 
influence of walking speed on pain by dichotomizing the sample into slow walkers (< 1.0 
m/sec, n = 24) and fast walkers (>1 m/s, n = 36).  Faster walkers reported slightly more pain 
relief (-6.7 + 18.4) than slower walkers (-3.3 + 18.6) during the self-selected walking task, 
but no significant differences were found (t58 = .711, p = .480).  Faster walkers had about the 
same pain relief as slow walkers during the fast walk task while wearing the SAI (slow 
walkers:  -4.7 + 17.7 mm; fast walkers: -3.5 + 15.4 mm; t58=.274, p = .785).     
  82 
Most participants (97%) reported the insoles were more comfortable in all the walking 
conditions.  Even with increased comfort, there were no significant decreases in knee pain 
when wearing the SAI during the shorter walks.  The degree of shoe comfort when wearing 
shock absorbing insoles has been linked with a reduction of self-reported lower extremity 
injuries in military recruits over a four month period.23  The authors concluded that short-
term comfort was an important factor in long-term injury prevention.  Our data suggest that 
an increase in shoe comfort does not equal a decrease in short-term knee pain in this 
population.  It is unknown what the long-term effect of SAI would be. 
The most important finding of our study was that of decreased pain when wearing the 
SAI during the 6MWT.  This finding supports our hypothesis that participants would report 
less knee pain when walking longer distances while wearing a SAI.  Participants reported a 
higher pain level under both conditions for the 6MWT compared with the shorter walking 
tasks (self-selected walk and fast walk) and reported a significant decrease in pain after 
walking for 6 minutes while wearing the SAI (p = .028) as compared to wearing only the test 
shoes.  Small but significant changes in knee pain are supported in the literature.  Small 
changes in VAS pain scores (13 mm ) were found to be significant in a group with 
symptomatic knee OA who took Glucosomine for 12 weeks.91   However, it is still 
questionable that the small change in knee pain (5.5mm on VAS) reported in this study was 
clinically significant.  We were unable to find a definition of a minimal clinically significant 
change in knee pain in a population with symptomatic knee OA, however, other in trauma 
patients ,9 mm was clinically significant.92, 93  It has also been suggested that people with 
greater pain require a greater change in the VAS score to achieve clinically significant pain 
relief.93  
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Most of the literature addressing  knee pain in those with knee OA has used the WOMAC 
pain subscore for comparisons at different time periods.30, 35, 40  The WOMAC pain subscore 
was used in this study to determine baseline pain, but because the WOMAC is not sensitive 
to pain changes in the same day it was not used to evaluate knee pain during walking tasks in 
this study.  No literature was found to compare our results in VAS pain scores after the 
6MWT over such a short intervention period.  All the available research found measuring 
immediate effects of an intervention were biomechanical studies which did report knee pain.  
 Certain participants clearly benefited more than others from the SAI during the 6MWT.  
We explored the data to see if some common characteristics could be discovered.  No 
significant differences were found when comparing the participants who reported a decrease 
in pain (57%, n = 34) while wearing the SAI compared with those who actually reported an 
increase in pain (32%, n = 19).  Post hoc t-test performed on these two groups revealed no 
differences in age, BMI, number of comorbidities, initial WOMAC pain subscore, or ASES 
pain subscore.  A higher percentage of retired people (35%) and those with a college degree 
(53%) reported a decrease in pain while wearing the SAI compared to those who reported an 
increase in pain (16% retired; 47% college).  We also explored the kinetic data to determine 
if any significant differences could be found.  Those who reported less pain on the 6MWT 
when wearing an SAI demonstrated a significantly higher peak external knee flexor moment 
(-.21 + .14 Nm/kg*m; t49 = -2.178, p = .034) compared to those who reported an increase in 
knee pain (-.11 + .138 Nm/kg*m).  Although this is an interesting finding, it is important to 
remember that the gait analyses were performed at slower GS over a much shorter distance 
than the 6MWT.  Therefore, we cannot make any inferences about the change in knee 
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moment and reported pain during the 6MWT.  No significant differences were found in the 
time to peak VGRF (p = .923), peak VGRF (p = .917) or rate of loading (p = .624).   
It has been suggested in the literature that African Americans are more likely to use 
complimentary medicine.94  In a large study  investigating the use of complimentary and 
alternative medicine (CAM) usage in persons with arthritis, African Americans were much 
more likely (89.1%) to report CAM usage compared to Caucasians (78%).94   In this 
investigation, a greater percentage of African Americans (60%) reported a decrease in pain 
during the 6MWT versus only 45% of Caucasians.  African Americans (n = 20) also reported 
a larger decrease in pain while wearing the SAI during the 6MWT (-8.4 mm) compared to 
Caucasians (-4 mm), however, this difference was not significant (p=.399).   
Examination of potential modifiers 
Another aim of this study was to determine if we could identify participant characteristics 
that might modify the effects of SAI.  We hypothesized that weight, severity of knee OA, 
presence of varus/valgus knee angle as determined by x-ray, initial WOMAC pain subscore, 
and/or Arthritis Self-efficacy (ASES) pain subscore would potentially be modifiers of the 
effectiveness of SAIs.  Our results indicate that none of the proposed participant 
characteristics measured in this investigation modified the effects of the SAI on pain.  
It is well documented that obesity and knee OA are strongly related.30  A direct 
relationship between body mass and knee joint forces has been reported.18  In a group of 
overweight and obese adults with symptomatic knee OA, it was determined that for every 
one pound of body weight lost, there was a 4-pound decrease in joint loading at the knee for 
each step.18  This supports the theory that the lighter the person is, the less forces are placed 
across the knee and therefore, potentially less knee pain.  Symptoms associated with OA, 
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such as joint pain, have not been well studied in either average or obese individuals.9  We 
hypothesized that lighter participants would report less pain than heavier participants while 
wearing the SAI.  Our data did not support our hypothesis (p = .682).  No differences were 
found in pain change scores between lighter people (range 54 – 72.8 kg, n=15) and heavier 
people (range 102.2 – 141 kg., n = 15).    
We hypothesized that participants with less severe knee OA as measured by the K-L 
grading scale would report less pain during the 6MWT while wearing the SAI.  No 
significant differences were found between participants with grade I (change in pain = -9 
mm, n=20) and participants with grade IV (change in pain = -4.1 mm, n = 13; p = .474 ).   
Participants with grade III knee OA severity reported the least amount of change in pain (-1.5 
mm) during the 6MWT while grade II benefited almost as much as grade I (change in pain = 
-7.5 mm).  This is not a surprising finding since it is generally accepted that severity of knee 
OA as graded on x-ray does not correlate well with symptoms.5, 28  These data support that 
people with even the lowest grade of knee OA severity as measured by x-ray may benefit 
from SAI during longer walking distances. 
We hypothesized participants with less pain as measured by the WOMAC pain subscore 
would report less pain during the 6MWT while wearing the SAI.  Our data does not support 
this hypothesis (p = .057).  Thirty-five percent of the sample reported very low levels of pain 
at the beginning of this study (WOMAC pain subscore < 7, range 4 – 20). As previously 
mentioned, it is possible that there was a floor effect with the pain measure.   
The amount and presence of knee malalignment has been linked to knee OA progression 
and functional decline.10  A landmark population study (n = 237) supports the idea that varus 
alignment of the knee is associated with medial knee OA progression and a valgus alignment 
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of the knee is associated with lateral knee OA.10  In our investigation, people with a varus 
alignment (n = 41) reported the greatest decrease in pain while wearing the SAI (- 6.6 mm) 
versus those with a valgus alignment (-4.3 mm, n = 13).  However, this decrease in pain did 
not reach a significant level (p = .632).  A greater degree of malalignment has been 
associated with higher pain levels.10  Therefore, it was hypothesized that people with less 
malalignment would report less pain during the 6MWT.  Although we did not find a 
significant difference (p = .627), we did notice a consistent finding of those with a lower 
degree of malalignment benefited more than those with a large malalignment.   Participants 
with a mild varus knee angle reported the largest decrease in knee pain during the 6MWT (-
8.5 + 22.4 mm) as compared to those with a more severe varus angle (-6 + 20.9 mm).  There 
were fewer persons with valgus alignment (n = 13).  However, the same pattern was still 
present.  Those with mild valgus reported a larger decrease in pain (-10.6 + 19.4 mm) 
compared to those with more severe valgus  (-5.6 + 8.1 mm). 
Self-efficacy is the belief that one has the capability to manage a situation to attain a 
desired outcome. Social cognitive theory states how well people complete a task is better 
predicted by their beliefs of their capabilities versus their actually capability.95  Self-efficacy 
as measured on the Arthritis Self-Efficacy Scale (ASES) has been associated with higher 
function and lower pain in those with symptomatic knee OA.96  The questions that make up 
the pain self-efficacy subscore focus on the participant’s ability to manage their pain both 
with and without medications. We hypothesized that those with a higher ASES pain subscore 
would report less pain while completing the 6MWT with the SAI.  However, our data failed 
to support our hypothesis.  In this investigation, those who reported a higher level of self 
efficacy (n=19, ASES score = 82.2) only reported a very small decrease in pain (< 1 mm on 
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the VAS scale) during the 6MWT when wearing the SAI.  In contrast, those with lower 
ASES scores regarding pain (42.1, n = 16) reported a much larger decrease in pain (12.3 mm 
on the VAS scale).  These data suggest that pain self-efficacy is not a significant factor in 
modifying the effects of the SAI.  Pain self-efficacy has been more closely correlated with 
self-report functional difficulty, whereas, functional self-efficacy has been more highly 
correlated with actual physical performance.28  Furthermore, in a group of women with knee 
OA, functional self-efficacy explained 51% of the variance of the distance walked during the 
6MWT while BMI, quadriceps strength and pain self-efficacy together only explained 
another 12% of the variance.96  No literature was found which identified the relationship 
between pain self-efficacy and pain with performing a physical task.      
In summary, we have no evidence to support that any of the selected patient 
characteristics modified the effects of the SAI during the 6MWT.  However, interesting 
observations were made in regards to who experienced the most pain relief.  Those who 
reported the most pain relief during the six minute walk while wearing the SAI were African 
American, had a grade 1 knee OA severity,  complained of milder knee pain, and had a mild 
knee malalignment regardless of the direction of the malalignment.   
Effect of SAI on Functional Mobility 
 Another aim of this investigation was to determine if SAI changed the functional 
mobility of persons with knee OA as measured by self-selected walking speed, fast walking 
speed and distance walked in the 6MWT.  There were no significant differences for walking 
speed (self-selected or fast) or distanced walked with SAI or without  SAI.  The self-selected 
walking speeds in this study (1.06 + .27 m/s) seem reasonable when compared to the 
literature.  A large cross-sectional study (n = 139) of persons with symptomatic knee OA 
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demonstrated a similar self-selected walking speed (1.09 m/s).45  The slightly higher gait 
speed reported in that study can be explained by the younger mean age (57 years) of the 
sample versus the sample in the current investigation (64 years).  Much lower walking speeds 
(.55 m/sec) have been reported in persons with the severest form of knee OA.44  Our sample 
consisted of  participants with all severity levels with only 23% demonstrated the most severe 
grade of knee OA on x-ray.  No studies were found which reported fast walking speeds in 
people with knee OA. 
The study was designed to examine the immediate effects of the SAI.  Walking is a 
highly repetitive task which individuals perform frequently.  Self-selected walking speed is 
associated with a participant’s “normal walk”.  In fact, the instructions to the participants 
were to “walk at your typical pace”.   The fast walking speed was also a self-selected pace.  
Participants were asked “to walk as quickly and as safely as you can”.    Therefore, it was not 
surprising to find participant’s walking speed did not change with the simple addition of a 
SAI.  It is possible that over a longer period of accommodation (weeks) of wearing the SAI, 
participants may adopt a different gait speed, however, we are unable to speculate on that 
outcome with these data.  
We hypothesized that participants would walk further during the 6MWT while wearing 
the SAI.  However, there were no significant differences found between the two SAI 
conditions.  Predicted 6MWT walking distance equations which account for individual 
height, weight, and age for both healthy males and females are available in the literature.97  
All subjects walked within the lower limits of predicted 6MWT distances under both 
conditions.   
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While pain was decreased during the 6MWT when wearing the SAI there was no 
associated increase in distance walked.  We have identified two possible reasons why people 
did not walk further even when reporting less pain while wearing the SAI during the 6MWT.  
First, participants chose their walking speed.  Even though they were instructed to walk at a 
pace to “cover as much ground as possible” during the time period, participants were able to 
walk at any pace.  Previously we discussed that even fast walking speeds were extremely 
consistent.  That consistency would account for the lack of change in walking distance during 
a timed walk.  Second, it is possible that the distanced walked during the 6MWT was 
affected by limited cardiovascular fitness as opposed to knee pain.  Many of the participants 
were overweight or obese and demonstrated labored breathing during and immediately after 
the 6MWT.                  
Effect of SAI on Lower Extremity Biomechanics 
Previous work investigating shoes with shock absorbing capabilities or shock absorbing 
insoles have indicated a reduced number of lower extremity injuries.23, 25, 26, 78  These 
researchers hypothesized that the decrease in injuries were secondary to an decrease in forces 
up the kinetic chain as a result of wearing a SAI.  We hypothesized that participants would 
demonstrate a decrease in the rate of loading (LR = peak VGRF/time to VGRF) when 
wearing the SAI because of the increased shock absorbing capabilities of the insole. We did 
not find a significant difference in the rate of loading rate between the two insert conditions 
(p = .486). 
Our loading rates (5.87, 5.94 BW/sec) were somewhat lower than previously reported 
(6.59 BW/s) in persons with knee OA.51 This can be explained by the higher walking speed 
(1.12 – 1.34 m/sec) of the participants in the previous study compared to our participants 
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(1.06 m/sec).  A decrease in loading rate can be accomplished by either increasing the time to 
achieve peak VGRF or by decreasing the peak VGRF or a combination of both.  We 
expected the time to reach peak VGRF would be longer in the SAI condition.  However, a 
decrease in the time to peak VGRF occurred in the SAI condition (without SAI : .200s; with 
SAI: .198s).   
Forty percent (n=24) of our sample walked at a speed less than 1 m/sec.   There is a 
limited amount of time one can devote to load acceptance during the stance phase.  It is 
possible that these slow walkers may have already maximized the time available for load 
acceptance during stance, therefore the addition of a SAI would not have increased the time 
to peak GRF.  In disease free individuals, the time to peak VGRF is estimated to be 12% of 
the stance time but can be much greater in people who walk slowly.47 Reported time to peak 
VGRF during loading response for people with knee OA is 25 – 28% of the stance time51, 98 
and 21% of the complete gait cycle time.64   Our participants demonstrated slightly longer 
time to reach peak VGRF (no SAI 28.6% stance; with SAI 28.9% stance).  Those who 
walked the slowest (.49 m/sec) took the longest to reach peak VGRF (no SAI = 45% stance; 
with SAI = 44% of stance).  However, when just analyzing the results of the fast walkers (>1 
m/s), the same trends (no difference between conditions and higher loading rate with SAI) 
were found.  
We hypothesized that peak VGRF during the loading response of stance would be 
decreased while walking with the addition of a SAI inside the shoe; however, our data did 
not support this hypothesis.  Similarly, there was no change in time to peak VGRF while 
wearing the SAI.  Peak VGRF values during walking with (1.08 times BW) and without 
(1.07 times BW) the SAI were very similar to those found in other gait studies investigating 
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walking patterns of people with knee OA (.91 – 1.06 times BW).46, 51, 64  The slightly lower 
peak VGRF values found in the literature correspond to slower walking speeds (.9 m/s) 
versus our faster mean walking speed (1.06 m/s). Our results reveal a very small increase in 
the peak VGRF while wearing the SAI.  Our findings are in an agreement to the work of 
Shiba et al63who reported a similar increase in peak VGRF of 1.8 – 2.1 %BW when 
comparing different types of SAI to shoes alone.   
 The majority of the studies found that comparing shoe inserts with a control condition 
used either a skin or a bone placed accelerometer to detect tibial loading rate and cannot be 
directly compared to our data.26, 57, 99  In general, these studies support a small but significant 
decrease in tibial loading rate when wearing shock absorbing foot wear.    
Only one study was found which used a force plate to determine changes in peak VGRF 
and reported time to peak VGRF.63 The authors concluded the attenuation of impact forces 
by the shock absorbing insole materials averaged 11%.  Upon careful inspection of their data, 
the greatest decrease in the slope of the impact loading curve occurred when a shock-
absorbing material resembling athletic shoe construction was placed in the shoe.  They found 
no difference in impact loading between different thicknesses of other SAI materials placed 
in the shoe.   These results suggest that an athletic shoe was more effective in decreasing 
loading rate than a SAI.  Our data lends support to this idea. It is possible our control 
condition (athletic walking shoe) already provided an excellent source of shock absorption, 
there by, the addition of a SAI would not be of added benefit.   
 We hypothesized that the addition of a SAI would increase the external knee flexor 
moment.  However, our data indicated no difference in the external flexion moment of the 
knee when wearing the SAI versus the control condition.  This would indicate that even with 
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the slight increase in loading rate, there is no difference in knee joint loading when wearing 
the SAI.  This is a positive finding which supports the use of SAI for walking.     
 The external knee flexion moment reported in this investigation (with SAI: .174 + .16 
Nm/kg*m), without SAI: .175 + .14 Nm/kg*m) is within the range reported by previous 
investigations (.29 + .16 Nm/kg*m).100  Others have reported slightly higher external knee 
flexor moment of 1.1 Nm/kg*m12 and 1.31 Nm/kg*m for females and 1.47 Nm/kg*m for 
males.45  The differences could be explained by higher mean BMI of our participants.  There 
is also some evidence which supports people with increased BMI protect their knees by 
decreasing the internal knee extensor moment.45   
To our knowledge, this is the first study which compared sagittal plane kinetics when 
using a SAI. Eng and Pierrynowski81 reported no differences in sagittal plane walking 
kinematics with the addition of a SAI, however, they did not measure joint kinetics. 
Measurement of knee joint moments provides a more direct indication of actual knee 
joint loads.12  The knee kinetic pattern during level walking in persons with knee OA have 
been well described.12, 44, 45, 51, 100, 101 The most important sagittal plane knee moment during 
loading response is the external flexion moment which occurs in response to the body weight 
aligning behind the center of mass.47   The external knee flexion moment is equal and 
opposite to the internal knee extension moment which controls knee flexion during the 
loading response.  This internal moment is primarily generated by muscle, soft and boney 
tissue forces in response to the external moment.  A large internal knee extension moment 
would indicate all of the soft and boney structures around the knee (including the muscles) 
are working harder to control knee flexion. Most of the current literature concerning insoles 
in people with knee OA is devoted to investigate effectiveness of wedged insoles.  The 
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theory behind wedged insoles is that they effect frontal plane movements and joint moments.  
Overall, wedged insoles have been found effective in decreasing the external adductor 
moment in persons with knee OA.68, 72  
 We also reported the average of the external knee moment from heel strike to peak 
VGRF.  This measure takes into account the forces at the knee over a period of time during 
the stance phase versus just one point in time.  The average external sagittal plane knee 
moment was less (.012 + .09 Nm/kg*m) when wearing the SAI as compared to no SAI (.018 
+ .08 Nm/kg*m) but this difference was not statistically significant (p = .361).  This finding 
indicates that during loading response of stance, there was no change in sagittal plane forces 
on the knee when wearing the SAI.      
 In summary, we did not see any changes in our kinetic dependent variables while wearing 
the SAI.  Thus, decreases in pain during the 6MWT with the SAI cannot be explained by 
changes in peak VGRF, time to peak VGRF, rate of loading or external knee flexion 
moments.  The lack of change in the kinetic variables agrees with the lack of change in the 
pain and functional mobility measures during the short walking tests.  It is not clear why 
individuals experienced decreased pain during the 6MWT.  It is possible that changes in 
biomechanics occur after prolonged walking. 
Limitations and Future Research 
 It is possible that our sample was not representative of the population with knee OA.  
However, we feel our sample was a good representation of the population with knee OA.  In 
general, we would expect a group of individuals with knee OA to be older, mostly female, 
and overweight or obese.102  More women than men (62%, 38% respectively) participated in 
this study.  The sample as a whole had a mean BMI of 31.9 and the mean age of this sample 
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was 64 years.  One-third (33%) of the sample was African American.  The 2000 Census 
report indicated that Forsyth County was 25.6% African American and 68.6% White.  In a 
recent study of over 3000 participants in North Carolina, radiographic knee OA prevalence in 
African Americans was estimated to be higher (32.4%) than their Caucasian counterparts 
(26.8%). 103.  However, it is a well documented that African Americans participate in 
research at a lower rate.104  This sample was convened from the general public from the 
Winston-Salem area who met inclusion criteria without specific racial targets.  Even so, this 
sample exceeded the average research participation rate of 31% for African Americans as 
well as the local population statistics (25%).    All of the study data were collected at a 
historical black university/college (HBCU) campus and participant recruitment was focused 
on local churches and low income senior service programs which most likely enhanced 
minority participation. 
A possible limitation to this project was that two lab visits were required to rule-out  
fatigue as a confounding variable for the 6MWT.  We controlled for differed levels of pain 
on testing days by having participants complete a WOMAC pain questionnaire on both data 
collection days.  Results indicate pain levels were not significantly different.  Another 
concern was that participant drop out would be high because of the two visits.  There were 
only four people who dropped from the study before completion.  Three of these participants 
called to report an unforeseeable event which prevented the second visit.  No one reported 
the second visit was an excessive burden to complete the study.   
Our theory of how SAIs would work to decrease pain revolved around changes in the 
sagittal plane, therefore, only sagittal plane moments were evaluated.  The lower extremity is 
a closed kinetic chain with redundancy in the system.  Even though we had a sound rationale 
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for looking for changes in the sagittal plane, because of this redundancy, changes may have 
occurred elsewhere in the system.  It is possible that some modification occurred in either the 
frontal or transverse planes of the knee.  Likewise, changes in hip or ankle moments could 
explain the decrease in knee pain when wearing the SAI while walking longer distances.  We 
also only analyzed gait biomechanics at a self-selected gait speed over a short distance.   Gait 
analysis in future studies should include ankle, knee and hip kinematics/kinetics in all planes 
as well as more challenging tasks such as fast walking..  
The type of shoes worn during the control condition was also a possible limitation.  It is 
possible that the athletic shoes chosen for this study already had adequate shock absorbing 
qualities for walking at self-selected speeds.  Therefore, the addition of a SAI was of no 
greater benefit.  Previous studies compared insoles to leather sole shoes or military boots.  It 
is possible that new materials and better construction of walking/running shoes may make a 
shock absorbing insole obsolete for people who want to walk at typical speeds.  Because of 
the higher forces generated when running or fast walking, the results of this study cannot be 
generalized to those activities.  People with knee OA are continually urged by health care 
practitioners to begin and maintain a walking program.  When walking for exercise, people 
tend to walk at a greater speed than “typical” walking speed.  Therefore, gait analysis 
performed at higher walking speeds to determine if SAI have an added shock absorbing 
benefit over athletic shoes alone would add to the current body of knowledge.             
 The method used to measure the rate of loading could have been a limitation to this 
study.   The use of a force plate to determine the rate of loading has been suggested as a valid 
noninvasive technique.  However, the most accurate method to measure shock absorbing 
properties occurring during gait is an accelerometer surgically mounted to the tibia.  Other 
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studies found comparing insoles used an accelerometer to determine immediate vertical 
accelerations at heel strike and/or loading response.  This was an impractical method for this 
study but should be considered for future investigations. 
 A few limitations occurred with the 6MWT.  We are unsure if participants gave their 
maximal effort during the 6MWT for both test conditions.  We could have administered the 
standardized rate of perceived exertion (RPE) scale after each 6MWT to document 
participant perception of effort given during the task.  It is also possible that participants 
changed the way they walked during the 6MWT.  We were unable to rule this out as a 
possibility because we did not perform a gait analysis before and after the 6MWT.  Future 
studies should include the investigation of effectiveness of shock absorbing insoles on knee 
pain when wearing the SAI for physical activity over an extended time period.  This time 
period should be long enough to allow gait modifications to occur if present, but short 
enough to disallow “bottom out” the SAI.  Comparative gait analysis could occur after a 
period of prolonged walking on the same day (6 – 10 minutes) or after using the SAI over an 
extended time (2 – 4 weeks).   
Clinical Relevance 
 Shock absorbing insoles have the potential capability to decrease knee pain and promote 
comfortable mobility in persons with knee OA during weight-bearing activities for prolonged 
time periods (e.g. 6 minutes of walking).  Shock absorbing insoles are currently a 
recommended intervention for persons with hip or knee OA to decrease pain.  Our 
investigation supports the current belief that SAI decreases knee pain in persons with knee 
OA when walking long distances.  However, the biomechanical mechanism of how the SAI 
decreases pain has not been found.  It has been assumed that SAIs would attenuate the 
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vertical ground reaction forces, thereby, decreases forces up the kinetic chain.  Our data do 
not support this assumption.  This investigation gives some support to the use of SAI for 
relief of knee pain when walking long distances.  However, it is possible that current athletic 
shoe construction offers adequate shock absorbing for walking shorter distances at slower 
gait speeds.   
Conclusion 
 Community dwelling adults with symptomatic knee OA reported a significant reduction 
in knee pain after walking for six minutes while wearing the SAI.  No participant 
characteristic was found which identified someone who might potentially benefit from the 
use of a SAI suggesting all persons benefited equally.   There were no significant differences 
in the loading rate or the sagittal plane knee moments.  Similar decreases in knee pain were 
not found when walking short distances (4.3 m) at either self-selected or fast walking speeds.  
No changes in functional mobility parameters (gait speed or distance walked during 6MWT) 
were noted.   Most people reported an increase comfort level when the SAI were placed in 
the shoe.  However, this increase in foot comfort did not translate into a decrease in knee 
pain when walking short distances.  
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Appendix A: 
 
Summary of power analysis for all outcome measures based on sixty (60) participants. 
 
Outcome Measure Mean Standard 
Deviation 
Clinically Significant 
Change 
Power 
VAS (mm) 41 26.7 10 .81 
Gait speed (m/sec) 1.0 .1 .3 1 
Gait endurance  
6MWT (meters)  
425 11.5 
 
50 1 
Loading rate 5.48 .94 1 1 
Peak external knee 
moment during loading 
response 
.016 .014 .5 1 
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Appendix B 
 
VISUAL ANALOG SCALE 
 
 
 
Worst Imaginable Pain 
 
No Pain 
 
 
 
Baseline:    ___________________   Post Walk:  ___________________ 
 
Test:    Self Selected Walk  Fast Walk  6MWT 
 
Condition:     With SAI  Without SAI 
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Appendix C 
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  104 
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 Appendix D 
  
Arthritis Self-Efficacy Scale 
 
In the following questions we’d like to know how your arthritis pain affects you.  For each of 
the following questions, please circle the number which corresponds to your certainty that 
you can perform the following tasks. 
 
Self-efficacy pain subscale: 
 
How certain are you that you can decrease your pain quite a bit?    
 
               
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
How certain are you that you can continue most of your daily activities? 
 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
How certain are you that you can keep your arthritis pain from interfering with your sleep?  
 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
How certain are you that you can make a small-to-moderate reduction in your arthritis pain 
by using methods other than taking extra medication? 
 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
How certain are you that you can make a large reduction in your arthritis pain by using 
methods other than taking extra medication? 
 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
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Self-efficacy function subscale: 
We would like to know how confident you are in performing certain daily activities.  For 
each of the following questions, please circle the number which corresponds to your certainty 
that you can perform the tasks without an assistive device or help from another person.  
Please consider what you routinely can do, not what would require a single extraordinary 
effort.        AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN: 
 
Walk 100 feet on flat ground in 20 seconds?  
(This is the equivalent of walking the walkway four times) 
               
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Walk 10 steps downstairs in 7 seconds? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Get out of an armless chair quickly, without using your hands for support? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Button and unbutton 3 medium-size buttons in a row in 12 seconds? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Cut 2 bite-size pieces of meat with a knife and fork in 8 seconds? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Turn an outdoor faucet all the way on and all the way off? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Scratch your upper back with both your right and left hands? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Get in and out of the passenger side of a car without assistance from another person and 
without physical aids? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Put on a long-sleeve front-opening shirt or blouse (without buttoning) in 8 seconds? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain  
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Self-efficacy other symptoms subscale: 
In the following questions, we would like to know how you feel about your ability to control 
your arthritis.  For each of the following questions, please circle the number which 
corresponds to the certainty that you can now perform the following activities or tasks. 
 
HOW CERTAIN ARE YOU THAT YOU CAN: 
 
Control your fatigue? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Regulate your activity so as to be active without aggravating your arthritis? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Do something to help yourself feel better if you are feeling blue? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Manage your arthritis symptoms so that you can do the things you enjoy doing? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
Deal with the frustration of arthritis? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
 
As compared to other people with arthritis like yours, how certain are you that you manage 
arthritis pain during your daily activities? 
 
Very Uncertain 1     2     3     4    5    6     7     8     9     10   Very Certain 
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Appendix E 
 
Inverse Dynamics Calculations103  
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Appendix F 
 
Subject ID _______ Weight (kg) _______           Height (m) _______        Date: ________ 
 
 
GAIT ANALYSIS DATA COLLECTION FORM 
 
   
 
 
 
NOTES: 
Without SAI  With SAI 
Gait 
Speed 
  S#NItrial# Data 
Collected 
Path 
ID 
   Gait  
Speed 
S#WItrial# Data 
Collected 
Path 
ID 
  
   ____NI01 
     
   ___WI01 
  
  
   ____ NI02 
     
   ___WI02 
  
  
   ____ NI03 
     
   ___WI03 
  
  
   ____ NI04 
     
   ___WI04 
  
  
   ____ NI05 
     
   ___WI05 
  
  
   ____ NI06 
     
   ___WI06 
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Appendix G 
 
Reliability of kinetic measures. 
 
Outcome Measure ICC(3,3)  
without SAI (SEM) 
ICC(3,3)  
with SAI  (SEM) 
Loading rate .941 (.23) 
 
.944 (.19) 
Peak external knee extension 
moment during Loading 
Response 
.981 (.002) .976 (.002) 
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Appendix H 
 
Participant Intake Form 
 
 
 
 1 Mr. 2 Mrs.  3 Ms.  4 Miss    
    5 Dr. 
Sex 
1 Male   2  Female 
Date of Birth 
|___|___-|___|___-_______ 
    Month         Day              Year   
        First Name Middle Name Last Name 
         Street Address 
          City State Zip Code Home Phone 
(           )            
Work Phone 
(            ) 
 
Height________    
_________ 
                       Feet                        
Inches 
           Marital Status   
       1 Married 
       2     Separated/Divorced     
         3 Living with significant other  
         4 Widowed 
         5 Single 
 
Weight____________ 
                        Pounds 
                                   What is your race / ethnicity?  Please check all that apply to you. 
      1 American Indian or Alaska Native      
      2    Asian  
      3   Black or African American  
 
4  Native Hawaiian or Other       
Pacific Islander                    
5 White  
6 Hispanic or Latino           
         
7 Not Hispanic  
 
  8 Other Race   
                       
                           What is the highest degree or level of school you have completed?     
      1 8t h grade or less      
      2 Some high school 
      3 High school graduate/ GED                    
4 Some college, but no degree 
5 Associate degree (AA, AS) 
6 Bachelor’s degree (BA, BS) 
7 Postgraduate 
degree 
                           Which best describes your current work situation? Please check only one. 
     1 Working FT 
     2 Working PT 
        3 Student 
                 
 4  Leave of Absence          
5 Unemployed      
6 Homemaker (full 
time) 
7 Homemaker (need help from others) 
8 Disabled, unemployed or retired due to ill health 
9 Retired (not due to ill health) 
10  Other (specify): ______________________  
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Appendix I 
 
Brief Medical History 
 
 
The following is a list of common health problems.  In the first column, please 
check (√) the box if you have the problem.  If you do check the box, please 
complete the second and third columns as well. 
 
Do you have  
the problem? 
Do you receive 
treatment  
for it? 
Does it limit  
your  
activities? 
1. Heart Disease 
□ Yes □ Yes □ Yes 
2. Angina (Chest 
Pain) □ Yes □ Yes □ Yes 
3. Pacemaker 
□ Yes □ Yes □ Yes 
4. Uncontrolled 
Diabetes □ Yes □ Yes □ Yes 
5. High Blood 
Pressure □ Yes □ Yes □ Yes 
6. Lung Disease 
□ Yes □ Yes □ Yes 
7. Diabetes 
□ Yes □ Yes □ Yes 
8. Ulcer or Stomach 
Disease □ Yes □ Yes □ Yes 
9. Kidney Disease 
□ Yes □ Yes □ Yes 
10. Liver Disease 
□ Yes □ Yes □ Yes 
11. Anemia/Other 
Blood Disease □ Yes □ Yes □ Yes 
12. Cancer 
□ Yes □ Yes □ Yes 
13. Depression 
□ Yes □ Yes □ Yes 
14. Back Pain 
□ Yes □ Yes □ Yes 
15. Rheumatoid 
Arthritis □ Yes □ Yes □ Yes 
16. Fibromyalgia 
□ Yes □ Yes □ Yes 
17. Vascular Disease 
□ Yes □ Yes □ Yes 
18. Infection 
□ Yes □ Yes □ Yes 
19. Inflammatory 
Bowel Disease □ Yes □ Yes □ Yes 
20. Psoriasis 
□ Yes □ Yes □ Yes 
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Appendix J 
 
Medications 
 
For each medication category below, please check the medications you currently take for 
your arthritis.  Indicate ALL the medications you take, whether a medical doctor prescribes 
them, or not. Do not indicate your medication dose or the number of pills you take. 
 
 Over the counter pain relievers (for example, Anacin, Nuprin, Bayer, Advil, 
Bufferin, Tylenol, Excedrin, Aleve, Motrin, etc.): 
 
 Prescribed pain relievers (for example, Ultram, Vicadin, Tylenol 3, etc.) 
 
 Prescribed Nonsteroidal anti-inflammatory drugs (NSAIDS) (for example, 
Naprosyn, Voltaren, Clinoril, Indocin, Relafen, Celebrex, Vioxx, etc.) 
 
 Glucocorticoids (for example, Prednisone, prednisolone, cortisone, decadron, 
etc.) 
 
 Anti-rheumatic medications (for example, Methotrexate, gold shots, Arava, 
Plaquenil, Enbrel, Auranofin, Sulfasalizine, Imuran, Penicilliamine, Cytoxan, 
Remicade, etc.) 
 
 Muscle relaxants (Flexeril, Parafon, Forte, Robaxin, Soma, etc.) 
 
 Antidepressants or drugs that help you sleep (Elavil, Nortriptyline, Pamelor, 
Prozac, Sinequan, Zoloft, Tylenol PM, Ambien, etc.) 
 
 Viscosupplements (or hyaluronic acid substitutes) for treatment of 
Osteoarthritis (Hyalgan, glucosamine, chondroitin, Synvisc, etc.) 
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Appendix K 
 
Functional Mobility Data Collection Form 
 
 
Condition:       With Insert   Without Insert 
 
Self Selected Gait Velocity: 
 
Trial 1: __________ sec                              Average:  ___________ sec 
 
Trial 2: __________ sec           4.2 meters/ Avg time = ________ m/sec 
 
Post walk VAS Score:  ______________ 
 
 
 
Fast Gait Velocity: 
 
Trial 1: __________ sec                              Average:  ___________ sec 
 
Trial 2: __________ sec           4.2 meters/ Avg time = ________ m/sec 
 
Post Walk VAS Score:  ______________ 
 
 
 
6 Minute Walk Test: 
 
Resting BP (prior to test):   _____________   
 
Distance walked: __________  feet   _______ in.    _______ meters 
 
Post Walk VAS Score:  _____________ 
 
Laps:  ____________ 
 
Assistive Device?  Y   N What kind?:  ____________ 
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Appendix L 
 
RADIOLOGIC EVALUATION 
 
DATA FORM 
 
Knee:  Left Right 
 
 
K-L Grading (OA Severity):  0 1 2 3 4 
 
 
Medial Joint Space:  ______________mm 
 
 
Lateral Joint Space:  ______________ mm 
 
 
Anatomical Hip-Knee-Ankle Angle:   _____________ degrees 
 
Mechanical Hip-Knee-Ankle Angle:  ______________ degrees 
 
 
Evaluated by:  ________________________________________________________ 
    Dr. Jordan Renner, MD 
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Appendix M 
 
Results of statistical analysis excluding participants with Total Knee Replacement (TKR) 
 
 With SAI Without SAI     
Dependent  
Variable Mean SD 95% CI Mean SD 95% CI 
 
F-value 
 
p-value 
 
ES 
 
Power 
 
VAS Pain Scale 
(mm):  
Self Selected speed  
(n=58) 
 
15.7 
 
 
 
13.7 
 
 
 
 
12.1 – 19.3 
 
 
22 
 
 
 
 
23.6 
 
 
 
10.6 – 19.9 
 
.069 
 
.793 
 
.001 
 
.058 
VAS Pain Scale 
(mm):  
Fast Gait Speed 
(n=58) 
18.1 
 
 
 
16.6 
 
 
 
13.7 – 22.4 
 
 
 
22 
 
 
 
23.6 
 
 
 
15.8 – 28.2 
 
 
 
3.298 
 
.075 .055 .431 
VAS Pain Scale 
(mm):  
6MWT (n=58) 
25.8 25.6 
 
 
19.1 – 32.5 
 
 
31.5 
 
 
28.2 
 
 
24.1 – 38.9 
 
 
5.334 
 
.025 .086 .622 
Time to peak VGRF  
(sec)  (n =56) 
.197 
 
.06 
 
.182 - .212 
 
.199 
 
.06 
 
.182 – .215 
 
.196 .660 .004 .072 
Peak VGRF 
(times BW) (n=56) 
1.08 
 
.09 
 
 
1.06 – 1.10 
 
 
1.07 
 
 
.09 
 
 
1.05 – 1.10 
 
 
1.958 
 
.167 .034 .280 
Loading Rate 
(times BW/sec) n=56) 
5.92 
 
1.78 
 
5.4 – 6.4 
 
5.92 
 
1.77 
 
5.4 – 6.4 
 
.083 .775 .002 .059 
Peak Knee Moment†  
(N/BW*HT)  (n=55) 
-.178 
 
 
.14 
 
 
-.217 - -.141 
 
 
-.176 
 
 
.155 
 
 
-.218 - -.134 
 
 
.096 .758 .022 .061 
Average Knee 
Moment (N/BW*HT) 
(n=55) 
-.014 
 
 
.093 
 
 
-.04 - -.011 
 
 
-.021 
 
 
.081 
 
 
-.043 - .001 
 
 
1.253 .268 .023 .196 
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